|
AAK1
|
|
|
|
NV1001
|
N2640 |
N2500
|
22848
|
AP2 associated kinase 1
|
|
|
ABL1
|
V1901 |
V1902 |
V9051 |
NV1011 |
N2520 |
N2520 |
25 |
c-abl oncogene 1, receptor tyrosine kinase |
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl; ABL1 |
|
ABL1 (E255K)
|
V5098
|
V6572
|
V5099
|
NV2251
|
N2520 |
|
25
|
c-abl oncogene 1, non-receptor tyrosine kinase
|
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl
|
|
ABL1 (F317I)
|
VA7000 |
VA7001
|
VA7002
|
NV2261
|
N2520 |
|
25
|
c-abl oncogene 1, receptor tyrosine kinase
|
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl; ABL2
|
|
ABL1 (F317L)
|
VA7003
|
VA7004
|
VA7005
|
NV2271
|
N2520 |
|
25
|
c-abl oncogene 1, receptor tyrosine kinase
|
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl; ABL2
|
|
ABL1 (H396P)
|
VA7006
|
VA7007
|
VA7008
|
NV2281
|
N2520 |
|
25
|
c-abl oncogene 1, receptor tyrosine kinase
|
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl; ABL3
|
|
ABL1 (M351T)
|
|
|
|
NV2291
|
N2520 |
|
25
|
c-abl oncogene 1, receptor tyrosine kinase
|
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl; ABL3
|
|
ABL1 (Q252H)
|
VA7009
|
VA7010
|
VA7011
|
NV2301
|
N2520 |
|
25
|
c-abl oncogene 1, receptor tyrosine kinase
|
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl; ABL4
|
|
ABL1 (T315I)
|
V5320
|
V6573
|
V5321
|
NV2321
|
|
N2500
|
25
|
c-abl oncogene 1, non-receptor tyrosine kinase
|
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl
|
|
ABL1 (V299L)
|
VA7012
|
VA7013
|
VA7014
|
|
|
|
25
|
c-abl oncogene 1, receptor tyrosine kinase
|
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl; ABL5
|
|
ABL1 (Y253F)
|
V5086
|
V6574
|
V5087
|
NV2311
|
N2520 |
|
25
|
c-abl oncogene 1, non-receptor tyrosine kinase
|
ABL; JTK7; p150; c-ABL; v-abl; bcr/abl
|
|
ABL2
|
VA7369
|
VA7370
|
VA7371
|
NV2331
|
N2520 |
N2520
|
27
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
ABLL, ARG
|
|
ACK
|
V4050
|
V6270
|
V4051
|
|
|
|
10188
|
tyrosine kinase, non-receptor, 2
|
TNK2; ACK1; ACK-1; p21cdc42Hs; FLJ44758; FLJ45547
|
|
ADK
|
|
|
|
NV2401
|
N2620 |
|
132
|
adenosine kinase
|
AK
|
|
AKT1
|
V1911
|
V1912
|
V9061
|
NV2411
|
N2640 |
|
207
|
v-akt murine thymoma viral oncogene homolog 1
|
AKT; PKB; RAC; PRKBA; MGC99656; PKB-ALPHA; RAC-ALPHA; AKT1
|
|
AKT1 (E17K)
|
|
|
|
NV2421
|
N2640 |
|
207
|
v-akt murine thymoma viral oncogene homolog 1
|
AKT; PKB; RAC; PRKBA; MGC99656; PKB-ALPHA; RAC-ALPHA; AKT1
|
|
AKT2
|
V3861
|
V3862
|
V9041
|
NV1031
|
N2640 |
N2500
|
208
|
AKT serine/threonine kinase 2
|
PKBB; PRKBB; PKBBETA; RAC-BETA; AKT2
|
|
AKT2 (E17K)
|
|
|
|
NV2431
|
N2640 |
|
208
|
AKT serine/threonine kinase 2
|
PKBB; PRKBB; PKBBETA; RAC-BETA; AKT2
|
|
AKT3
|
V4010
|
V6272
|
V4011
|
|
N2640 |
|
1000
|
v-akt murine thymoma viral oncogene homolog 3
|
PKBG; PRKBG; STK-2; PKB-GAMMA; RAC-gamma; RAC-PK-gamma; DKFZp434N0250
|
|
AKT3 (E17K)
|
|
|
|
NV2441
|
N2640 |
|
1000
|
v-akt murine thymoma viral oncogene homolog 3
|
PKBG; PRKBG; STK-2; PKB-GAMMA; RAC-gamma; RAC-PK-gamma; DKFZp434N0250
|
|
AKT3 (G171R)
|
|
|
|
NV2451
|
N2640 |
|
1000
|
v-akt murine thymoma viral oncogene homolog 3
|
PKBG; PRKBG; STK-2; PKB-GAMMA; RAC-gamma; RAC-PK-gamma; DKFZp434N0250
|
|
ALK (L1196M)
|
VA7372
|
VA7373
|
VA7374
|
|
|
|
238
|
ALK receptor tyrosine kinase
|
ALK- CD246, NBLST3
|
|
ALK1
|
|
|
|
NV2391
|
N2650 |
|
94
|
activin A receptor like type 1
|
ACVRLK1, ALK-1, ALK1, HHT, HHT2, ORW2, SKR3, TSR-I
|
|
ALK2
|
V4492
|
V6272
|
V4493
|
NV2341
|
N2650 |
|
90
|
activin A receptor, type I
|
FOP; ACVR1; SKR1; TSRI; ACTRI; ACVR1A; ACVRLK2
|
|
ALK2 (G328V)
|
|
|
|
NV2351
|
N2650 |
|
90
|
activin A receptor, type I
|
ACTRI, ACVR1A, ACVRLK2, ALK2, FOP, SKR1, TSRI
|
|
ALK2 (G356D)
|
|
|
|
NV2361
|
N2650 |
|
90
|
activin A receptor, type I
|
ACTRI, ACVR1A, ACVRLK2, ALK2, FOP, SKR1, TSRI
|
|
ALK2 (Q207D)
|
|
|
|
NV2371
|
N2650 |
|
90
|
activin A receptor, type I
|
ACTRI, ACVR1A, ACVRLK2, ALK2, FOP, SKR1, TSRI
|
|
ALK2 (R206H)
|
|
|
|
NV2381
|
N2650 |
|
90
|
activin A receptor, type I
|
ACTRI, ACVR1A, ACVRLK2, ALK2, FOP, SKR1, TSRI
|
|
ALK3
|
|
|
|
NV2471
|
N2650 |
|
657
|
bone morphogenetic protein receptor type 1A
|
10q23del, ACVRLK3, ALK3, CD292, SKR5, BMPR1A
|
|
ALK4
|
V4508
|
V6575
|
V4509
|
NV1021
|
|
N2500
|
91
|
activin A receptor, type IB
|
SKR2; ACTRIB; ACVRLK4, ACVR1B
|
|
ALK6
|
V4052
|
V6273
|
V4053
|
|
|
|
658
|
bone morphogenetic protein receptor, type IB
|
BMPR1B; ALK-6; CDw293
|
|
AMPK (A1/B1/G1)
|
V1921
|
V1922
|
V9021
|
see PRKAA1
|
|
|
A1: 5562
B1: 5564
G1: 5571
|
protein kinase AMP-activated catalytic subunit alpha 1
protein kinase AMP-activated non-catalytic subunit beta 1
protein kinase AMP-activated non-catalytic subunit gamma 1
|
AMPK; AMPKa1; MGC33776; MGC57364; PRKAA1
|
|
AMPK (A1/B1/G2)
|
V4012
|
V6274
|
V4013
|
see PRKAA1
|
|
|
A1: 5562
B1: 5564
G1: 51422
|
protein kinase AMP-activated catalytic subunit alpha 1
protein kinase AMP-activated non-catalytic subunit beta 1
protein kinase AMP-activated non-catalytic subunit gamma 2
|
AMPK; AMPKa1; MGC33776; MGC57364; PRKAA1
|
|
AMPK (A1/B1/G3)
|
VA7015
|
VA7016
|
VA7017
|
see PRKAA1
|
|
|
A1: 5562
B1: 5564
G3: 53632
|
protein kinase AMP-activated catalytic subunit alpha 1
protein kinase AMP-activated non-catalytic subunit beta 1
protein kinase AMP-activated non-catalytic subunit gamma 3
|
AMPK, AMPKa1, HAMPKb, AMPKG3
|
|
AMPK (A1/B2/G1)
|
VA7018
|
VA7019
|
VA7020
|
see PRKAA1
|
|
|
A1: 5562
B2: 5565
G1: 5571
|
protein kinase AMP-activated catalytic subunit alpha 1
protein kinase AMP-activated non-catalytic subunit beta 2
protein kinase AMP-activated non-catalytic subunit gamma 1
|
AMPK, AMPKa1, PRKAA1, PRKAB2, PRKAG1 AMPKG
|
|
AMPK (A1/B2/G2)
|
VA7021
|
VA7022
|
VA7023
|
see PRKAA1
|
|
|
A1: 5562
B2: 5565
G2: 51422
|
protein kinase AMP-activated catalytic subunit alpha 1
protein kinase AMP-activated non-catalytic subunit beta 2
protein kinase AMP-activated non-catalytic subunit gamma 2
|
AMPK, AMPK2, AMPKa2, PRKAA, PRKAA2, PRKAB2, PRKAG, AAKG, AAKG2, CMH6, H91620p, WPWS
|
|
AMPK (A2/B1/G1)
|
V4014
|
V6275
|
V4015
|
see PRKAA2
|
|
|
A2: 5563
B1: 5564
G1: 5571
|
protein kinase AMP-activated catalytic subunit alpha 2
protein kinase AMP-activated non-catalytic subunit beta 1
protein kinase AMP-activated non-catalytic subunit gamma 1
|
AMPK; AMPK2; PRKAA; AMPKa2
|
|
AMPK (A2/B1/G2)
|
VA7378
|
VA7379
|
VA7380
|
see PRKAA2
|
|
|
A2: 5563
B1: 5564
G2: 51422
|
protein kinase AMP-activated catalytic subunit alpha 2
protein kinase AMP-activated non-catalytic subunit beta 1
protein kinase AMP-activated non-catalytic subunit gamma 1
|
AMPK, AMPK2, AMPKa2, PRKAA, PRKAA2, PRKAB1, PRKAG2, AAKG, AAKG2, CMH6, H91620p, WPWS, AMPK, HAMPKb
|
|
AMPK (A2/B2/G1)
|
VA7024
|
VA7025
|
VA7026
|
see PRKAA2
|
|
|
A2: 5563
B1: 5565
G1: 5571
|
protein kinase AMP-activated catalytic subunit alpha 2
protein kinase AMP-activated non-catalytic subunit beta 2
protein kinase AMP-activated non-catalytic subunit gamma 1
|
AMPK, AMPKa1, PRKAA1, PRKAB2, PRKAG2 AMPKG
|
|
AMPK (A2/B2/G2)
|
VA7027
|
VA7028
|
VA7029
|
see PRKAA2
|
|
|
A2: 5563
B2: 5565
G2: 51422
|
protein kinase AMP-activated catalytic subunit alpha 2
protein kinase AMP-activated non-catalytic subunit beta 2
protein kinase AMP-activated non-catalytic subunit gamma 2
|
AMPK, AMPK2, AMPKa2, PRKAA, AAKG, AAKG2, CMH6, H91620p, WPWS
|
|
ASK1/MAP3K5
|
V3881
|
V3882
|
V9481
|
|
|
|
4217
|
mitogen-activated protein kinase kinase kinase 5
|
ASK1; MEKK5; MAPKKK5; MAP3K5
|
|
Aurora A
|
V1931
|
V1932
|
V9081
|
NV1041
|
N2640 |
N2500
|
6790
|
aurora kinase A
|
AIK; ARK1; AURA; BTAK; STK6; STK7; STK15; AURORA2; MGC34538; AURKA
|
|
Aurora B
|
V3971
|
V3972
|
V9181
|
NV1051
|
N2640 |
N2500
|
9212
|
aurora kinase B
|
AIK2; AIM1; ARK2; AurB; IPL1; STK5; AIM-1; STK12; aurkb-sv1; aurkb-sv2; AURKB
|
|
Aurora C
|
VA7381
|
VA7382
|
VA7383
|
NV1061
|
N2640 |
N2500
|
6795
|
aurora kinase C
|
AURKC, AIE2, AIK3, ARK3, AurC, HEL-S-90, SPGF5, STK13, aurora-C
|
|
AXL
|
V3961
|
V3962
|
V9171
|
NV1071
|
N2640 |
N2500
|
558
|
AXL receptor tyrosine kinase
|
UFO; JTK11; AXL
|
|
BCR-RET
|
VA7030
|
VA7031
|
VA7032
|
|
|
|
5979
|
ret proto-oncogene
|
PTC; MTC1; HSCR1; MEN2A; MEN2B; CDHF12; CDHR16; RET-ELE1
|
|
BLK
|
VA7384
|
VA7385
|
VA7386
|
NV2461
|
N2520 |
N2520
|
640
|
BLK proto-oncogene, Src family tyrosine kinase
|
MODY11
|
|
BMP2K
|
|
|
|
NV1091
|
N2640 |
N2500
|
55589
|
BMP2 inducible kinase
|
BIKE, HRIHFB2017
|
|
BMPR2
|
VA7387
|
VA7388
|
VA7389
|
|
|
|
659
|
bone morphogenetic protein receptor type 2
|
BMPR-II, BMPR3, BMR2, BRK-3, POVD1, PPH1, T-ALK
|
|
BMX
|
V4512
|
V6576
|
V4513
|
NV1101
|
N2520 |
N2520
|
660
|
BMX non-receptor tyrosine kinase
|
ETK; PSCTK2; PSCTK3
|
|
BRAF (V600E)
|
|
|
|
NV2481
|
N2640 |
|
|
|
|
|
BRK
|
V4054
|
V6276
|
V4055
|
NV1941
|
N2520 |
N2520
|
5753
|
PTK6 protein tyrosine kinase 6
|
PTK6; FLJ42088
|
|
BRSK1
|
VA7390
|
VA7391
|
VA7392
|
NV2491
|
N2640 |
|
84446
|
BR serine/threonine kinase 1
|
hSAD1
|
|
BRSK2
|
VA7393
|
VA7394
|
VA7395
|
NV1111
|
N2640 |
N2500
|
9024
|
BR serine/threonine kinase 2
|
C11orf7, PEN11B, SAD1, SADA, STK29
|
|
BTK
|
V2941
|
V2942
|
V9071
|
N2441
|
N2640 |
N2500
|
695
|
Bruton agammaglobulinemia tyrosine kinase
|
AT; ATK; BPK; XLA; IMD1; AGMX1; PSCTK1; MGC126261; MGC126262; BTK
|
|
BTK (C481S)
|
VA7033
|
VA7034
|
VA7035
|
NV2501
|
N2640 |
|
695
|
Bruton agammaglobulinemia tyrosine kinase
|
AT; ATK; BPK; XLA; IMD1; AGMX1; PSCTK1; MGC126261; MGC126262; BTK
|
|
BTK (E41K)
|
|
|
|
NV2511
|
N2640 |
|
695
|
Bruton agammaglobulinemia tyrosine kinase
|
AT; ATK; BPK; XLA; IMD1; AGMX1; PSCTK1; MGC126261; MGC126262; BTK
|
|
BTK (P190K)
|
|
|
|
NV2521
|
N2640 |
|
695
|
Bruton agammaglobulinemia tyrosine kinase
|
AT; ATK; BPK; XLA; IMD1; AGMX1; PSCTK1; MGC126261; MGC126262; BTK
|
|
CAMK1
|
|
|
|
NV2531
|
N2630 |
|
695
|
calcium/calmodulin dependent protein kinase I
|
CAMKI
|
|
CAMK1D
|
|
|
|
NV2541
|
N2630 |
|
57118
|
calcium/calmodulin dependent protein kinase ID
|
CKLiK, CaM-K1, CaMKID
|
|
CAMK1γ
|
V4016
|
V6277
|
V4017
|
NV2551
|
N2630 |
|
57172
|
calcium/calmodulin-dependent protein kinase IG
|
VWS1; CLICKIII; dJ272L16.1
|
|
CAMK2D
|
VA7036
|
VA7037
|
VA7038
|
NV2571
|
N2640 |
|
817
|
calcium/calmodulin dependent protein kinase II delta
|
CAMKD
|
|
CAMK2α
|
V4018
|
V6278
|
V4019
|
NV2561
|
N2630 |
|
815
|
calcium/calmodulin-dependent protein kinase II alpha
|
CAMKA; KIAA0968
|
|
CAMK2β
|
VA7396
|
VA7397
|
VA7398
|
|
|
|
816
|
calcium/calmodulin dependent protein kinase II beta
|
CAM2, CAMK2, CAMKB, MRD54, CAMK2beta
|
|
CAMK2γ
|
V3531
|
V3532
|
V9201
|
NV2581
|
N2630 |
|
818
|
calcium/calmodulin-dependent protein kinase II gamma
|
CAMK; CAMKG; CAMK-II; FLJ16043; MGC26678; CAMK2G
|
|
CAMK4
|
V2951
|
V2952
|
V9091
|
|
|
|
814
|
calcium/calmodulin-dependent protein kinase IV
|
CaMK-GR; MGC36771; CAMK4
|
|
CAMKK1
|
V4470
|
V6279
|
V4471
|
|
|
|
84254
|
calcium/calmodulin-dependent protein kinase kinase 1, alpha
|
CAMKKA; MGC34095; DKFZp761M0423
|
|
CDC7/DBF4
|
V5088
|
V6577
|
V5089
|
|
|
|
8317
|
cell division cycle 7 homolog (S. cerevisiae)
|
Hsk1; CDC7L1; HsCDC7; huCDC7
|
|
CDK1/CyclinA1
|
VA7399
|
VA7400
|
VA7401
|
|
|
|
CDK1: 983
Cyclin A1: 8900
|
cyclin dependent kinase 1
cyclin A1
|
CDC2, CDC28A, P34CDC2
Cyclin A1- CT146
|
|
CDK1/CyclinA2
|
V2961
|
V2962
|
V9211
|
|
|
|
CDK1: 983
Cyclin A2: 890
|
cyclin dependent kinase 1
cyclin A2
|
CDC2; CDC28A; P34CDC2; MGC111195; DKFZp686L20222; CDK1
|
|
CDK1/Cyclin B1
|
|
|
|
CDK1: NV2701
Cyclin B1: NV2601
|
N2630 |
|
CDK1: 983
Cyclin B1: 891
|
cyclin dependent kinase 1
cyclin B1
|
CDC2, CDC28A, P34CDC2
|
|
CDK1/Cyclin E1
|
|
|
|
CDK1: NV2701
Cyclin E1: NV2641
|
N2630 |
|
CDK1: 983
Cyclin E1: 898
|
cyclin dependent kinase 1
cyclin E1
|
CDC2, CDC28A, P34CDC2
|
|
CDK2/Cyclin A1
|
VA7039
|
VA7040
|
VA7041
|
CDK2: NV2781
Cyclin A1: NV2591
|
N2640 |
|
CDK2: 1017
Cyclin A1: 8900
|
cyclin dependent kinase 2
cyclin A1
|
CDKN2; p33(CDK2)
|
|
CDK2/Cyclin E2
|
VA7042
|
VA7043
|
VA7044
|
|
|
|
1017
|
cyclin dependent kinase 2
cyclin E2
|
CDKN2; p33(CDK2)
|
|
CDK2/CyclinA2
|
V2971
|
V2972
|
V9221
|
|
|
|
CDK2: 1017
Cyclin A2: 890
|
cyclin dependent kinase 2
cyclin A2
|
p33(CDK2); CDK2
|
|
CDK2/CyclinE1
|
V4488
|
V6280
|
V4489
|
CDK2: NV2781
Cyclin E1: NV2641
|
N2640 |
|
CDK2: 1017
Cyclin E1: 898
|
cyclin dependent kinase 2
cyclin E1
|
p33(CDK2)
|
|
CDK3/CyclinE1
|
V4490
|
V6281
|
V4491
|
CDK3: NV2801
Cyclin E1: NV2641
|
N2640 |
|
CDK3: 1018
Cyclin E1: 898
|
cyclin dependent kinase 3
cyclin E1
|
|
|
CDK4/Cyclin D1
|
|
|
|
CDK4: NV2811
Cyclin D1: NV2621
|
N2640 |
|
CDK4: 1019
Cyclin D1: 595
|
cyclin dependent kinase 4
cyclin D1
|
CMM3, PSK-J3
|
|
CDK4/Cyclin D3
|
|
|
|
CDK4: NV2811
Cyclin D3: NV2631
|
N2640 |
|
1019
|
cyclin dependent kinase 4
cyclin D3
|
CMM3, PSK-J3
|
|
CDK5/p25
|
V3231
|
V3232
|
V9541
|
|
|
|
CDK5: 1020
p25: 8851
|
cyclin dependent kinase 5
cyclin dependent kinase 5 regulatory subunit 1 (cleaved version)
|
|
|
CDK5/p35
|
V3271
|
V3272
|
V9551
|
CDK5: NV1121
p35: NV2821
|
N2640 |
|
CDK5: 1020
p35: 8851
|
cyclin dependent kinase 5
cyclin dependent kinase 5 regulatory subunit 1
|
LIS7; PSSALRE
|
|
CDK5/p39
|
|
|
|
CDK5: NV1121
p39: NV2831
|
N2640 |
|
CDK5: 1020
p39: 8941
|
cyclin dependent kinase 5
cyclin dependent kinase 5 regulatory subunit 2
|
LIS7; PSSALRE
|
|
CDK6/Cyclin D1
|
|
|
|
CDK6: NV2841
Cyclin D1: NV2621
|
N2640 |
|
CDK6: 1021
Cyclin D1: 595
|
cyclin-dependent kinase 6
cyclin D1
|
PLSTIRE; MGC59692
|
|
CDK6/CyclinD3
|
V4510
|
V6282
|
V4511
|
|
|
|
CDK6: 1021
Cyclin D3: 896
|
cyclin-dependent kinase 6
cyclin D3
|
PLSTIRE; MGC59692
|
|
CDK7
|
|
|
|
NV2851
|
N2640 |
|
1022
|
cyclin dependent kinase 7
|
CAK, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15
|
|
CDK7/CyclinH1/MNAT1
|
VA7402
|
VA7403
|
VA7404
|
|
|
|
CDK7: 1022
Cyclin H1: 902
MNAT1: 4331
|
cyclin dependent kinase 7
cyclin H
MNAT1 component of CDK activating kinase
|
CDK7- CAK, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15, CAP35, MAT1, RNF66, TFB3, CAK, CycH, p34, p37
|
|
CDK8/Cyclin C
|
|
|
|
CDK8: NV2861
Cyclin C: NV2611
|
N2620 |
|
CDK8: 1024
Cyclin C: 892
|
cyclin dependent kinase 8
|
K35
|
|
CDK9/CyclinK
|
V4104
|
V6283
|
V4105
|
CDK9: NV2871
Cyclin K: NV2661
|
N2620 |
|
CDK9: 1025
Cyclin K: 8812
|
cyclin-dependent kinase 9
cyclin K
|
TAK; C-2k; CTK1; CDC2L4; PITALRE
|
|
CDK9/Cyclin T1
|
|
|
|
CDK9: NV2871
Cyclin T1: NV2681
|
N2620 |
|
CDK9: 1025
Cyclin T1: 904
|
cyclin-dependent kinase 9
cyclin T1
|
TAK; C-2k; CTK1; CDC2L4; PITALRE
|
|
CDK10/Cyclin L2
|
|
|
|
CDK10: NV2711
Cyclin L2: NV2671
|
N2640 |
|
CDK10: 8558
Cyclin L2: 81669
|
cyclin dependent kinase 10
cyclin L2
|
ALSAS, PISSLRE
|
|
CDK14/Cyclin Y
|
|
|
|
CDK14: NV2721
Cylin Y: NV2691
|
N2640 |
|
CDK14: 5218
Cyclin Y: 219771
|
cyclin dependent kinase 14
cyclin Y
|
PFTAIRE1, PFTK1
|
|
CDK15/Cyclin Y
|
|
|
|
CDK15: NV2731
Cylin Y: NV2691
|
N2640 |
|
CDK15: 65061
Cyclin Y: 219771
|
cyclin dependent kinase 15
cyclin Y
|
ALS2CR7, PFTAIRE2, PFTK2
|
|
CDK16/Cyclin Y
|
|
|
|
CDK16: NV2741
Cylin Y: NV2691
|
N2640 |
|
CDK16: 5127
Cyclin Y: 2197712
|
cyclin dependent kinase 16
cyclin Y
|
PCTAIRE, PCTAIRE1, PCTGAIRE, PCTK1
|
|
CDK17/Cyclin Y
|
|
|
|
CDK17: NV2751
Cylin Y: NV2691
|
N2640 |
|
CDK17: 5128
Cyclin Y: 219771
|
cyclin dependent kinase 17
cyclin Y
|
PCTAIRE2, PCTK2
|
|
CDK18/Cyclin Y
|
|
|
|
CDK18: NV2761
Cylin Y: NV2691
|
N2640 |
|
CDK18: 5129
Cyclin Y: 219771
|
cyclin dependent kinase 18
cyclin Y
|
PCTAIRE, PCTAIRE3, PCTK3
|
|
CDK19/Cyclin C
|
|
|
|
CDK19: NV2771
Cyclin C: NV2611
|
N2620 |
|
CDK19: 23097
Cyclin C: 892
|
cyclin dependent kinase 19
cyclin C
|
CDC2L6, CDK11, bA346C16.3
|
|
CDK20/Cyclin H
|
|
|
|
CDK20: NV2791
Cyclin H: NV2651
|
N2640 |
|
CDK20: 23662
Cyclin H: 902
|
cyclin dependent kinase 20
cyclin H
|
CCRK, CDCH, P42, PNQALRE
|
|
CDKL1
|
|
|
|
NV2881
|
N2650 |
|
8814
|
cyclin dependent kinase like 1
|
KKIALRE, P42
|
|
CDKL2
|
|
|
|
NV2891
|
N2650 |
|
8999
|
cyclin dependent kinase like 2
|
KKIAMRE, P56
|
|
CDKL3
|
|
|
|
NV2901
|
N2650 |
|
51265
|
cyclin dependent kinase like 3
|
NKIAMRE
|
|
CDKL5
|
|
|
|
NV2911
|
N2650 |
|
6792
|
cyclin dependent kinase like 5
|
CFAP247, EIEE2, ISSX, STK9
|
|
CHK1
|
V1941
|
V1942
|
V9241
|
NV2921
|
N2630 |
|
1111
|
CHK1 checkpoint homolog (S. pombe)
|
CHK1; CHEK1
|
|
CHK2
|
V4020
|
V6284
|
V4021
|
NV2931
|
N2640 |
|
11200
|
checkpoint kinase 2
|
CDS1; CHEK2; LFS2; RAD53; hCds1; HuCds1; PP1425
|
|
CK1α1
|
V4484
|
V6285
|
V4485
|
|
|
|
1452
|
casein kinase 1, alpha 1
|
CK1; CK1a; CKIa; HLCDGP1; PRO2975; CK1alpha; CKIalpha; CSNK1A1
|
|
CK1α1L
|
VA7183
|
VA7184
|
VA7185
|
NV2951
|
N2640 |
|
122011
|
casein kinase 1 alpha 1 like
|
CK1
|
|
CK1γ1
|
V4100
|
V6578
|
V4101
|
|
|
|
53944
|
casein kinase 1, gamma 1
|
CSNK1G1
|
|
CK1γ2
|
|
|
|
NV1181
|
N2640 |
N2500
|
1455
|
casein kinase 1 gamma 2
|
CK1g2
|
|
CK1δ
|
VA7405
|
VA7406
|
VA7407
|
NV2961
|
N2620 |
|
1453
|
casein kinase 1 delta
|
CSNK1D, ASPS, CKI-delta, CKId, CKIdelta, FASPS2, HCKID
|
|
CK1ε
|
V4160
|
V6286
|
V4161
|
NV2971
|
N2620 |
|
1454
|
casein kinase 1, epsilon
|
HCKIE; CKIepsilon; MGC10398; CSNK1E
|
|
CK1ε (R178C)
|
VA7408
|
VA7409
|
VA7410
|
|
|
|
1454
|
casein kinase 1, epsilon
|
CSNK1E, CKIe, CKIepsilon, HCKIE
|
|
CK2α1
|
V4482
|
V6287
|
V4483
|
NV2981
|
N2640 |
|
1457
|
casein kinase 2, alpha 1 polypeptide
|
CKII; CK2A1; CSNK2A1
|
|
CK2α2
|
VA7597
|
VA7598
|
VA7599
|
NV1191
|
N2640 |
N2500
|
1459
|
casein kinase 2 alpha 2
|
CK2A2, CK2alpha', CSNK2A1
|
|
c-KIT
|
V4498
|
V6579
|
V4499
|
NV1491
|
N2520 |
N2520
|
3815
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
PBT; SCFR; KIT; CD117
|
|
c-KIT (A829P)
|
|
|
|
NV3321
|
N2520 |
|
3815
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
PBT; SCFR; KIT; CD117
|
|
c-KIT (d557-558)
|
VA7045
|
VA7046
|
VA7047
|
|
|
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
c-KIT (D816E)
|
VA7048
|
VA7049
|
VA7050
|
|
|
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
c-KIT (D816H)
|
|
|
|
NV3331
|
N2520 |
|
3815
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
PBT; SCFR; KIT; CD117
|
|
c-KIT (D816V)
|
|
|
|
NV3341
|
N2630 |
|
3815
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
PBT; SCFR; KIT; CD117
|
|
c-KIT (D820E)
|
VA7051
|
VA7052
|
VA7053
|
|
|
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
c-KIT (L576P)
|
|
|
|
NV3351
|
N2520 |
|
3815
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
PBT; SCFR; KIT; CD117
|
|
c-KIT (N822K)
|
VA7054
|
VA7055
|
VA7056
|
|
|
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
c-KIT (T670E)
|
VA7411
|
VA7412
|
VA7413
|
|
|
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
c-KIT( V559D, T670I)
|
|
|
|
NV3371
|
N2620 |
|
3815
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
PBT; SCFR; KIT; CD117
|
|
c-KIT (V559D V654A)
|
VA7057
|
VA7058
|
VA7059
|
NV3381
|
N2520 |
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
c-KIT (V559D)
|
VA7060
|
VA7061
|
VA7062
|
NV3361
|
N2520 |
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
c-KIT (V560G D816V)
|
VA7063
|
VA7064
|
VA7065
|
|
|
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
c-KIT (V560G)
|
VA7066
|
VA7067
|
VA7068
|
|
|
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
c-KIT (Y823D)
|
VA7069
|
VA7070
|
VA7071
|
|
|
|
3815
|
KIT proto-oncogene, receptor tyrosine kinase
|
PBT; SCFR; C-Kit; CD117; MASTC
|
|
CLK1
|
V4056
|
V6288
|
V4057
|
NV1131
|
N2640 |
N2500
|
1195
|
CDC-like kinase 1
|
CLK; STY; CLK/STY
|
|
CLK2
|
VA7414
|
VA7415
|
VA7416
|
NV1141
|
N2630 |
N2500
|
|
CDC-like kinase 2
|
|
|
CLK3
|
V4162
|
V6289
|
V4163
|
|
|
|
1198
|
CDC-like kinase 3
|
PHCLK3; PHCLK3/152; FLJ22858
|
|
CLK4
|
VA7072
|
VA7073
|
V7074
|
NV1151
|
N2630 |
N2500
|
57396
|
CDC-like kinase 4
|
|
|
c-MER
|
V3541
|
V3542
|
V9561
|
NV3561
|
N2630 |
|
10461
|
c-mer proto-oncogene tyrosine kinase
|
MER; RP38; c-mer; MGC133349; MERTK
|
|
c-MER (A708S)
|
|
|
|
NV3571
|
N2630 |
|
10461
|
c-mer proto-oncogene tyrosine kinase
|
MER; RP38; c-mer; MGC133349; MERTK
|
|
COQ8B
|
|
|
|
NV2941
|
N2640 |
|
79934
|
coenzyme Q8B
|
ADCK4, NPHS9
|
|
CSK
|
V2981
|
V2982
|
V9251
|
NV1171
|
N2520 |
N2520
|
1445
|
c-src tyrosine kinase
|
MGC117393; CSK
|
|
DAPK1
|
V4096
|
V6390
|
V4097
|
|
|
|
1612
|
death-associated protein kinase 1
|
DAPK; DKFZp781I035
|
|
DAPK2
|
VA7417
|
VA7418
|
VA7419
|
NV2991
|
N2640 |
|
23604
|
death-associated protein kinase 2
|
DRP-1, DRP1
|
|
DAPK3
|
VA7420
|
VA7421
|
VA7422
|
|
|
|
1613
|
death-associated protein kinase 3
|
DLK, ZIP, ZIPK
|
|
DCAMKL1
|
VA7075
|
VA7076
|
VA7077
|
|
|
|
9201
|
doublecortin like kinase 1
|
CL1; DCLK; CLICK1; DCDC3A; DCLK1
|
|
DCAMKL3
|
|
|
|
NV3001
|
N2640 |
|
85443
|
doublecortin like kinase 3
|
CLR, DCAMKL3, DCDC3C, DCK3
|
|
DDR1
|
|
|
|
N2451
|
N2520 |
N2520
|
780
|
discoidin domain receptor tyrosine kinase 1
|
|
|
DDR2
|
V4058
|
V6391
|
V4059
|
NV1201
|
N2520 |
N2520
|
4921
|
discoidin domain receptor tyrosine kinase 2
|
TKT; MIG20a; NTRKR3; TYRO10
|
|
DDR2 (N456S)
|
|
|
|
NV3011
|
N2520 |
|
4921
|
discoidin domain receptor tyrosine kinase 2
|
TKT; MIG20a; NTRKR3; TYRO10
|
|
DGKA
|
VA7606
|
VA7607
|
VA7608
|
|
|
|
1606
|
diacylglycerol kinase alpha
|
DAGK, DAGK1, DGK-alpha
|
|
DGKB
|
VA7609
|
VA7610
|
VA7611
|
|
|
|
1607
|
diacylglycerol kinase beta
|
DAGK2, DGK, DGK-BETA
|
|
DGKE
|
VA7612
|
VA7613
|
VA7614
|
|
|
|
8526
|
diacylglycerol kinase epsilon
|
GK; AHUS7; DAGK5; DAGK6; NPHS7
|
|
DGKQ
|
VA7615
|
VA7616
|
VA7617
|
|
|
|
1609
|
diacylglycerol kinase theta
|
DAGK, DAGK4, DAGK7
|
|
DGKZ
|
VA7618
|
VA7619
|
VA7620
|
|
|
|
8525
|
diacylglycerol kinase zeta
|
DAGK5, DAGK6, DGK-ZETA, hDGKzeta
|
|
DNAPK
|
V4106
|
NA
|
V4107
|
|
N2520 |
|
5591
|
DNA-dependent Protein Kinase (native enzyme purified from HeLa cells)
|
HYRC; p350; DNAPK; DNPK1; HYRC1; IMD26; XRCC7; DNA-PKC
|
|
DRAK1 (STK17A)
|
VA7078
|
VA7079
|
VA7080
|
|
|
|
9263
|
serine/threonine kinase 17a
|
STK17A
|
|
DRAK2
|
VA7081
|
VA7082
|
VA7083
|
NV4271
|
N2630 |
|
9262
|
serine/threonine kinase 17b
|
STK17B
|
|
DYRK1A
|
VA7423
|
VA7424
|
VA7425
|
NV3031
|
N2640 |
|
1859
|
dual specificity tyrosine phosphorylation regulated kinase 1B
|
DYRK, DYRK1, HP86, MNB, MNBH, MRD7
|
|
DYRK1B
|
VA7426
|
VA7427
|
VA7428
|
NV1211
|
N2640 |
N2500
|
9149
|
dual specificity tyrosine phosphorylation regulated kinase 1A
|
AOMS3, MIRK
|
|
DYRK2
|
V5090
|
V6580
|
V5091
|
NV3041
|
N2640 |
|
8445
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
|
|
|
DYRK3
|
VA7429
|
VA7430
|
VA7431
|
|
|
|
8444
|
dual specificity tyrosine phosphorylation regulated kinase 3
|
DYRK5, RED, REDK, hYAK3-2
|
|
EGFR
|
V3831
|
V3832
|
V9261
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (A763-Y764 ins FHEA)
|
VA7084
|
VA7085
|
VA7086
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (C775S T790M L858R)
|
VA7087
|
VA7088
|
VA7089
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (C797S L858R)
|
VA7090
|
VA7091
|
VA7092
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (C797S)
|
VA7093
|
VA7094
|
VA7095
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (d746)
|
VA7432
|
VA7433
|
VA7434
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (d746-750 C797A)
|
VA7096
|
VA7097
|
VA7098
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (d746-750 C797S)
|
VA7099
|
VA7100
|
VA7101
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (d746-750 T790M C797S L858R)
|
VA7102
|
VA7103
|
VA7104
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (d746-750 T790M C797S)
|
VA7105
|
VA7106
|
VA7107
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (d746-750 T790M L798I)
|
VA7108
|
VA7109
|
VA7110
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (d746-750 T790M L858R)
|
VA7111
|
VA7112
|
VA7113
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (d746-750 T790M)
|
VA7114
|
VA7115
|
VA7116
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (d746-750)
|
VA7117
|
VA7118
|
VA7119
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (D770-N771insNPG)
|
VA7120
|
VA7121
|
VA7122
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (G719C)
|
VA7435
|
VA7436
|
VA7437
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (L858R)
|
V5322
|
V6581
|
V5323
|
|
|
|
1956
|
epidermal growth factor receptor
|
ERBB; HER1; mENA; ERBB1; PIG61
|
|
EGFR (L861Q)
|
V4102
|
V6582
|
V4103
|
|
|
|
1956
|
epidermal growth factor receptor
|
ERBB; HER1; mENA; ERBB1; PIG61
|
|
EGFR (T790M C797S)
|
VA7123
|
VA7124
|
VA7125
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (T790M L858R C797S)
|
VA7126
|
VA7127
|
VA7128
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (T790M)
|
V4506
|
V6583
|
V4507
|
|
|
|
1956
|
epidermal growth factor receptor
|
ERBB; HER1; mENA; ERBB1; PIG61
|
|
EGFR (T790M, D770_N771insNPG)
|
VA7129
|
VA7130
|
VA7131
|
|
|
|
1956
|
epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)
|
ERBB; HER1; mENA; ERBB1; PIG61; EGFR
|
|
EGFR (T790M, L858R)
|
V5324
|
V6584
|
V5325
|
|
|
|
1956
|
epidermal growth factor receptor
|
ERBB; HER1; mENA; ERBB1; PIG61
|
|
EIF2AK1 (HRI)
|
VA7132
|
VA7133
|
VA7134
|
|
|
|
27102
|
eukaryotic translation initiation factor 2 alpha kinase 1
|
HCR; HRI
|
|
EIF2AK2
|
V5328
|
V6585
|
V5329
|
|
|
|
5610
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
PKR; PRKR; EIF2AK1
|
|
EIF2AK4
|
VA7438
|
VA7439
|
VA7440
|
NV3051
|
N2640
|
|
440275
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
GCN2, PVOD2
|
|
EML4-ALK
|
VA7357
|
VA7358
|
VA7359
|
|
|
|
EML4: 27436
ALK: 238
|
EMAP like 4
ALK receptor tyrosine kinase
|
EML4- C2orf2, ELP120, EMAP-4, EMAPL4, ROPP120
ALK- CD246, NBLST3
|
|
EPHA1
|
V3561
|
V3562
|
V9271
|
NV1221
|
N2520 |
N2520
|
2041
|
EPH; EPHT; EPHT1; MGC163163; EPHA1
|
EML4- C2orf2, ELP120, EMAP-4, EMAPL4, ROPP120
ALK- CD246, NBLST3
|
|
EPHA2
|
VA7441
|
VA7442
|
VA7443
|
NV1231
|
N2520 |
N2520
|
1969
|
EPH receptor A2
|
ARCC2, CTPA, CTPP1, CTRCT6, ECK
|
|
EPHA3
|
VA7135
|
VA7136
|
VA7137
|
NV3061
|
N2650 |
|
2042
|
EPH receptor A3
|
EK4; ETK; HEK; ETK1; HEK4; TYRO4
|
|
EPHA4
|
VA7444
|
VA7445
|
VA7446
|
NV1241
|
N2520 |
N2520
|
2043
|
EPH receptor A7
|
2900005C20Rik, AI385584, Cek8, Hek8, Sek, Sek1, Tyro1, rb
|
|
EPHA5
|
|
|
|
NV1251
|
N2520 |
N2520
|
2044
|
EPH receptor A5
|
CEK7, EHK-1, EHK1, EK7, HEK7, TYRO4
|
|
EPHA6
|
VA7138
|
VA7139
|
VA7140
|
NV1261
|
N2640 |
N2500
|
285220
|
EPH receptor A6
|
EHK2; EK12; EPA6; EHK-2; HEK12; PRO57066
|
|
EPHA7
|
VA7447
|
VA7448
|
VA7449
|
NV1271
|
N2640 |
N2500
|
13841
|
EPH receptor A5
|
Cek11, Ebk, Ehk3, Hek11, Mdk1
|
|
EPHA8
|
|
|
|
NV1281
|
N2520 |
N2520 |
2046
|
EPH receptor A8
|
EEK, EK3, HEK3
|
|
EPHB1
|
VA7141
|
VA7142
|
VA7143
|
NV3071
|
N2630 |
|
2047
|
EPH receptor B1
|
ELK; NET; Hek6; EPHT2
|
|
EPHB2
|
|
|
|
NV1291
|
N2520 |
N2520
|
2048
|
EPH receptor B2
|
CAPB, DRT, EK5, EPHT3, ERK, Hek5, PCBC, Tyro5
|
|
EPHB3
|
|
|
|
NV1301
|
N2520 |
N2520
|
2049
|
EPH receptor B3
|
EK2, ETK2, HEK2, TYRO6
|
|
EPHB4
|
VA7450
|
VA7451
|
VA7452
|
NV1311
|
N2520 |
N2520
|
2050
|
EPH receptor B4
|
CMAVM2, HFASD, HTK, LMPHM7, MYK1, TYRO11
|
|
ERK1/MAPK3
|
V1951
|
V1952
|
V9281
|
NV1671
|
|
N2500
|
5595
|
mitogen-activated protein kinase 3
|
ERK1; PRKM3; P44ERK1; P44MAPK; HS44KDAP; HUMKER1A; MGC20180; MAPK3
|
|
ERK2/MAPK1
|
V1961
|
V1962
|
V9291
|
NV1641
|
|
N2500
|
5594
|
mitogen-activated protein kinase 1
|
ERK; p38; p40; p41; ERK2; ERT1; MAPK2; PRKM1; PRKM2; P42MAPK; p41mapk; MAPK1
|
|
ERN1 (IRE1)
|
VA7144
|
V7145
|
V7146
|
NV1321
|
N2640 |
N2500
|
2081
|
endoplasmic reticulum to nucleus signaling 1
|
IRE1; IRE1P; IRE1a; hIRE1p
|
|
ERN2
|
VA7360
|
VA7361
|
VA7362
|
NV3081
|
N2640 |
|
10595
|
endoplasmic reticulum to nucleus signaling 2
|
IRE1-BETA, IRE1b, IRE2p, hIRE2p, IRE2
|
|
FAK
|
V1971
|
V1972
|
V9301
|
NV1921
|
N2640 |
N2520
|
5747
|
PTK2 protein tyrosine kinase 2
|
FAK; FADK; FAK1; FRNK; pp125FAK; PTK2
|
|
FER
|
VA7453
|
VA7454
|
VA7455
|
NV1331
|
N2640 |
N2500
|
14158
|
fms/fps related protein kinase
|
AV082135, C330004K01Rikt, Fert2, Fer
|
|
FES
|
V1981
|
V1982
|
V9311
|
NV3091
|
N2630 |
|
2242
|
FES proto-oncogene, tyrosine kinase
|
FPS; FES
|
|
FGFR1
|
V2991
|
V2992
|
V9321
|
NV1341
|
N2640 |
N2500
|
2260
|
fibroblast growth factor receptor 1
|
CEK; FLG; OGD; FLT2; KAL2; BFGFR; CD331; FGFBR; HBGFR; N-SAM; FLJ99988; FGFR1
|
|
FGFR1 (V561M)
|
VA7456
|
VA7457
|
VA7458
|
|
|
|
2260
|
ibroblast growth factor receptor 1
|
CEK; FLG; OGD; FLT2; KAL2; BFGFR; CD331; FGFBR; HBGFR; N-SAM; FLJ99988; FGFR1
|
|
FGFR1OP-FGFR1
|
VA7147
|
VA7148
|
VA7149
|
|
|
|
FGFR1OP: 11116br>
FGFR1: 2260
|
FGFR1 oncogene partner
fibroblast growth factor receptor 1
|
FGFR1OP- FOP
FGFR1- CEK; FLG; OGD; FLT2; KAL2; BFGFR; CD331; FGFBR; HBGFR; N-SAM; FLJ99988; FGFR1
|
|
FGFR2
|
V4060
|
V6392
|
V4061
|
NV1351
|
N2640 |
N2500
|
2263
|
fibroblast growth factor receptor 2
|
BEK; JWS; BBDS; CEK3; CFD1; ECT1; KGFR; TK14; TK25; BFR-1; CD332; K-SAM; FLJ98662
|
|
FGFR2 (N549H)
|
VA7150
|
VA7151
|
VA7152
|
|
|
|
2263
|
fibroblast growth factor receptor 2
|
BEK; JWS; BBDS; CEK3; CFD1; ECT1; KGFR; TK14; TK25; BFR-1; CD332; K-SAM; FLJ98662
|
|
FGFR2 (R612T)
|
VA7153
|
VA7154
|
VA7155
|
|
|
|
2263
|
fibroblast growth factor receptor 2
|
BEK; JWS; BBDS; CEK3; CFD1; ECT1; KGFR; TK14; TK25; BFR-1; CD332; K-SAM; FLJ98663
|
|
FGFR2 (V564F)
|
VA7156
|
VA7157
|
VA7158
|
|
|
|
2263
|
fibroblast growth factor receptor 2
|
BEK; JWS; BBDS; CEK3; CFD1; ECT1; KGFR; TK14; TK25; BFR-1; CD332; K-SAM; FLJ98664
|
|
FGFR3
|
VA7459
|
VA7460
|
VA7461
|
NV1361
|
N2640 |
N2500
|
2261
|
ibroblast growth factor receptor 3
|
ACH; CEK2; JTK4; CD333; HSFGFR3EX
|
|
FGFR3 (G697C)
|
VA7159
|
VA7160
|
VA7161
|
NV3101
|
N2640 |
|
2261
|
ibroblast growth factor receptor 3
|
ACH; CEK2; JTK4; CD333; HSFGFR3EX
|
|
FGFR3 (K650E)
|
V5082
|
V6598
|
V5083
|
|
|
|
2261
|
ibroblast growth factor receptor 3
|
ACH; CEK2; JTK4; CD333; HSFGFR3EX
|
|
FGFR3 (K650Q)
|
VA7162
|
VA7163
|
VA7164
|
|
|
|
2261
|
ibroblast growth factor receptor 3
|
ACH; CEK2; JTK4; CD333; HSFGFR3EX
|
|
FGFR4
|
V4062
|
V6393
|
V4063
|
NV1371
|
N2640 |
N2500
|
2264
|
fibroblast growth factor receptor 4
|
TKF; JTK2; CD334; MGC20292
|
|
FGR
|
VA7462
|
VA7463
|
VA7464
|
NV1381
|
N2520 |
N2520
|
2268
|
FGR proto-oncogene, Src family tyrosine kinase
|
SRC2, c-fgr, c-src2, p55-Fgr, p55c-fgr, p58-Fgr, p58c-fgr
|
|
FIP1L1-PDGFRα
|
VA7165
|
VA7166
|
VA7167
|
|
|
|
FIP1L1: 81608
PDGFRα: 5156
|
factor interacting with PAPOLA and CPSF1
platelet-derived growth factor receptor, alpha polypeptide
|
FIP1L1- Rhe; FIP1; hFip1
PDGFRα- CD140A; PDGFR2; MGC74795; RHEPDGFRA; PDGFRA
|
|
FLT1
|
V3001
|
V3002
|
V9331
|
NV3111
|
N2630 |
|
2321
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
|
FLT; VEGFR1; FLT1
|
|
FLT3
|
V4064
|
V6394
|
V4065
|
NV1391
|
N2640 |
N2500
|
2322
|
fms-related tyrosine kinase 3
|
FLK2; STK1; CD135; FLK-2
|
|
FLT3 (D835H)
|
|
|
|
NV3121
|
N2640 |
|
2322
|
fms-related tyrosine kinase 3
|
FLK2; STK1; CD135; FLK-2
|
|
FLT3 (D835V)
|
|
|
|
NV3131
|
N2640 |
|
2322
|
fms-related tyrosine kinase 3
|
FLK2; STK1; CD135; FLK-2
|
|
FLT3 (D835Y)
|
V4514
|
V6586
|
V4515
|
NV3141
|
N2640 |
|
2322
|
fms-related tyrosine kinase 3
|
FLK2; STK1; CD135; FLK-2
|
|
FLT3 (K663Q)
|
|
|
|
NV3151
|
N2630 |
|
2322
|
fms-related tyrosine kinase 3
|
FLK2; STK1; CD135; FLK-2
|
|
FLT3 (N841I)
|
|
|
|
NV3161
|
N2640 |
|
2322
|
fms-related tyrosine kinase 3
|
FLK2; STK1; CD135; FLK-2
|
|
FLT3 (R834Q)
|
|
|
|
NV3171
|
N2640 |
|
2322
|
fms-related tyrosine kinase 3
|
FLK2; STK1; CD135; FLK-2
|
|
FLT3 (ITD-NPOS)
|
VA7168
|
VA7169
|
VA7170
|
|
|
|
2322
|
fms-related tyrosine kinase 3
|
FLK2; STK1; CD135; FLK-2
|
|
FLT3 (N676K)
|
VA7171
|
VA7172
|
VA7173
|
|
|
|
2322
|
fms-related tyrosine kinase 3
|
FLK2; STK1; CD135; FLK-2
|
|
FMS
|
V4022
|
V6395
|
V4023
|
NV1161
|
N2520 |
N2520
|
1436
|
colony stimulating factor 1 receptor
|
colony stimulating factor 1 receptor
|
|
FRK
|
VA7465
|
VA7466
|
VA7467
|
NV1401
|
N2520 |
N2520
|
2444
|
fyn related Src family tyrosine kinase
|
GTK, PTK5, RAK
|
|
FYN A
|
V3571
|
V3572
|
V9341
|
NV1411
|
N2520 |
N2520
|
2534
|
FYN oncogene related to SRC, FGR, YES
|
SLK; SYN; MGC45350; FYN
|
|
FYN (Y531F)
|
|
|
|
NV3181
|
N2520 |
|
2534
|
FYN oncogene related to SRC, FGR, YES
|
SLK; SYN; MGC45350; FYN
|
|
GAK
|
|
|
|
NV1421
|
N2640 |
N2500
|
2580
|
cyclin G associated kinase
|
DNAJ26, DNAJC26
|
|
GCK
|
VA7174
|
VA7175
|
VA7176
|
NV1621
|
N2640 |
N2500
|
5871
|
mitogen-activated protein kinase kinase kinase kinase 2
|
MAP4K2; BL44; RAB8IP
|
|
GLK
|
VA7177
|
VA7178
|
VA7179
|
NV1631
|
N2640 |
N2500
|
8491
|
mitogen-activated protein kinase kinase kinase kinase 3
|
MAP4K3; MAPKKKK3; MEKKK3; RAB8IPL1
|
|
GOPC-ROS1
|
VA7180
|
VA7181
|
VA7182
|
|
|
|
GOPC: 57120
ROS1: 6098
|
golgi associated PDZ and coiled-coil motif containing
ROS proto-oncogene 1, receptor tyrosine kinase
|
GOPC- CAL; FIG; PIST; GOPC1; dJ94G16.2
ROS1- ROS; MCF3; c-ros-1
|
|
GRK5
|
V3981
|
V3982
|
V9351
|
|
|
|
2869
|
G protein-coupled receptor kinase 5
|
GPRK5; GRK5
|
|
GSK3α
|
V3051
|
V3052
|
V9361
|
NV3191
|
N2620 |
|
2931
|
glycogen synthase kinase 3 alpha
|
DKFZp686D0638; GSK3A
|
|
GSK3β
|
V1991
|
V1992
|
V9371
|
NV3201
|
N2620 |
|
2932
|
glycogen synthase kinase 3 beta
|
GSK3B
|
|
Haspin
|
VA7468
|
VA7469
|
VA7470
|
|
|
|
83903
|
histone H3 associated protein kinase
|
GSG2
|
|
HCK
|
VA7186
|
VA7187
|
VA7188
|
NV3211
|
N2520 |
|
3055
|
HCK proto-oncogene, Src family tyrosine kinase
|
JTK9; p59Hck; p61Hck
|
|
HER2
|
V3891
|
V3892
|
V9381
|
|
|
|
2064
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
|
NEU; NGL; HER2; TKR1; CD340; HER-2; HER-2/neu; ERBB2
|
|
HER2 (A775-G776 ins YVMA)
|
VA7189
|
VA7190
|
VA7191
|
|
|
|
2064
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
|
NEU; NGL; HER2; TKR1; CD340; HER-2; HER-2/neu; ERBB2
|
|
HER2 (G776VC)
|
VA7192
|
VA7193
|
VA7194
|
|
|
|
2064
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
|
NEU; NGL; HER2; TKR1; CD340; HER-2; HER-2/neu; ERBB2
|
|
HER2 (P780 Y781 ins GSP)
|
VA7195
|
VA7196
|
VA7197
|
|
|
|
2064
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
|
NEU; NGL; HER2; TKR1; CD340; HER-2; HER-2/neu; ERBB2
|
|
HER2 (V777L)
|
VA7198
|
VA7199
|
VA7200
|
|
|
|
2064
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)
|
NEU; NGL; HER2; TKR1; CD340; HER-2; HER-2/neu; ERBB2
|
|
HER4
|
V3101
|
V3102
|
V9391
|
|
|
|
2066
|
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian)
|
HER4; MGC138404; p180erbB4; ERBB4
|
|
HGK
|
VA7471
|
VA7472
|
VA7473
|
|
|
|
9448
|
mitogen-activated protein kinase kinase kinase kinase 4
|
FLH21957, HEL-S-31, HGK, MEKKK4, NIK, MAP4K2
|
|
HIPK1
|
V4066
|
V6396
|
V4067
|
|
|
|
204851
|
homeodomain interacting protein kinase 1
|
Myak; Nbak2; KIAA0630; MGC26642; MGC33446; MGC33548
|
|
HIPK2
|
|
|
|
NV3221
|
N2640 |
|
28996
|
homeodomain interacting protein kinase 2
|
PRO0593
|
|
HIPK3
|
V4164
|
V6397
|
V4165
|
NV3231
|
N2640 |
|
10114
|
homeodomain interacting protein kinase 3
|
PKY; YAK1; DYRK6; FIST3
|
|
HIPK4
|
|
|
|
NV3241
|
N2640 |
|
147746
|
homeodomain interacting protein kinase 4
|
|
|
HPK1
|
V4098
|
V6398
|
V4099
|
NV1611
|
N2640 |
N2500
|
11184
|
mitogen-activated protein kinase kinase kinase kinase 1
|
MAP4K1
|
|
ICK
|
|
|
|
NV3251
|
N2620 |
|
22858
|
ciliogenesis associated kinase 1
|
ECO, EJM10, ICK, LCK2, MRK, hICK, CILK1
|
|
IGF1R
|
V3581
|
V3582
|
V9401
|
NV3261
|
N2630 |
|
3480
|
insulin-like growth factor 1 receptor
|
IGFR; CD221; IGFIR; JTK13; MGC18216; MGC142170; MGC142172; IGF1R
|
|
IKKe
|
VA7201
|
VA7202
|
VA7203
|
NV1431
|
N2640 |
N2500
|
9641
|
inhibitor of nuclear factor kappa B kinase subunit epsilon
|
IKKE; IKKI; IKK-E; IKK-I; IKKepsilon
|
|
IKKα
|
V4068
|
V6399
|
V4069
|
|
|
|
1147
|
conserved helix-loop-helix ubiquitous kinase
|
IKK1; IKKA; IKBKA; TCF16; NFKBIKA; IKK-alpha; CHUK
|
|
IKKβ
|
V4502
|
V6587
|
V4503
|
|
|
|
3551
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
IKK2; IKKB; NFKBIKB; IKK-beta, IKBKB
|
|
InsR
|
V3901
|
V3902
|
V9411
|
NV3271
|
N2630 |
|
3643
|
insulin receptor
|
HHF5; CD220; INSR
|
|
InsR (R1201Q)
|
VA7474
|
VA7475
|
VA7476
|
|
|
|
3643
|
insulin receptor
|
CD220, HHF5
|
|
IRAK1
|
VA7477
|
VA7478
|
VA7479
|
NV3281
|
N2630 |
|
3654
|
interleukin 1 receptor associated kinase 1
|
IRAK, pelle
|
|
IRAK3
|
|
|
|
NV1441
|
N2640 |
N2500
|
11213
|
interleukin 1 receptor associated kinase 3
|
ASRT5, IRAKM
|
|
IRAK4
|
V2621
|
V2622
|
V9421
|
NV1451
|
N2640 |
N2500
|
51135
|
interleukin 1 receptor associated kinase 4
|
IPD1; REN64; NY-REN-64; IRAK4
|
|
ITK
|
V3191
|
V3192
|
V9431
|
NV1461
|
N2640 |
N2500
|
3702
|
IL2-inducible T-cell kinase
|
EMT; LYK; PSCTK2; MGC126257; MGC126258; ITK; IL2-inducible T-cell kinase
|
|
JAK1
|
VA7207
|
VA7208
|
VA7209
|
|
|
|
3716
|
Janus kinase 1
|
JAK1AB, JTK3, JAK1
|
|
JAK1 (R724H)
|
VA7204
|
VA7205
|
VA7206
|
|
|
|
3716
|
Janus kinase 1
|
JAK1AB, JTK3, JAK1
|
|
JAK2
|
|
|
|
NV3291
|
N2640 |
|
3717
|
Janus kinase 2
|
JTK10, THCYT3
|
|
JAK2 (JH1 Domain)
|
|
|
|
NV3311
|
N2640 |
|
3717
|
Janus kinase 2
|
JTK10, THCYT3
|
|
JAK2 (V617F)
|
|
|
|
NV3301
|
N2640 |
|
3717
|
Janus kinase 2
|
JTK10, THCYT3
|
|
JAK3
|
V3701
|
V3702
|
V9441
|
NV1471
|
N2640 |
N2520
|
3718
|
Janus kinase 3
|
JAKL; LJAK; JAK-3; L-JAK; JAK3_HUMAN; JAK3
|
|
JNK1 (Mouse)
|
V4070
|
V6440
|
V4071
|
|
|
|
26419
|
mitogen-activated protein kinase 8
|
JNK; Mapk8; Prkm8; SAPK1; AI849689
|
|
JNK1 (Human)
|
|
|
|
NV1701
|
N2640 |
N2500
|
5599
|
mitogen-activated protein kinase 8
|
JNK, JNK1, PRKM8, SAPK1, JNK-46, JNK1A2, SAPK1c, JNK21B1/2
|
|
JNK2
|
VA7210
|
VA7211
|
VA7212
|
NV1711 |
N2640
|
N2500
|
5601
|
mitogen-activated protein kinase 9
|
NK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK
|
|
JNK3
|
V3821
|
V3822
|
V9461
|
NV1481
|
N2640 |
N2500
|
5602
|
mitogen-activated protein kinase 10
|
JNK3; JNK3A; PRKM10; p493F12; FLJ12099; FLJ33785; MGC50974; p54bSAPK; MAPK10
|
|
KDR
|
V2681
|
V2682
|
V9471
|
|
|
|
3791
|
kinase insert domain receptor (a type III receptor tyrosine kinase)
|
FLK1; CD309; VEGFR; VEGFR2; KDR
|
|
KHS1
|
V4108
|
V6441
|
V4109
|
NV3501
|
N2640 |
|
11183
|
mitogen-activated protein kinase kinase kinase kinase 5
|
KHS; GCKR; MAP4K5; MAPKKKK5
|
|
KSR1 (L639F)
|
VA7594
|
VA7595
|
VA7596
|
|
N2640 |
|
8844
|
kinase suppressor of ras 1
|
KSR, RSU2
|
|
LATS1
|
|
|
|
NV1501
|
N2640 |
N2500
|
9113
|
large tumor suppressor kinase 1
|
WARTS, wts
|
|
LATS2
|
|
|
|
NV1511
|
N2640 |
N2500
|
26524
|
large tumor suppressor kinase 2
|
KPM
|
|
LCK
|
V2691
|
V2692
|
V9491
|
NV1521
|
N2520 |
N2520
|
3932
|
lymphocyte-specific protein tyrosine kinase
|
YT16; p56lck; pp58lck; LCK
|
|
LIMK1
|
VA7480
|
VA7481
|
VA7482
|
NV3391
|
N2640 |
|
3984
|
LIM domain kinase 1
|
LIMK, LIMK-1
|
|
LIMK2
|
|
|
|
NV1531
|
N2640 |
N2520
|
3985
|
LIM domain kinase 2
|
|
|
LRRK2
|
V4474
|
V6442
|
V4475
|
NV3401
|
N2630 |
|
120892
|
leucine-rich repeat kinase 2
|
PARK8; RIPK7; ROCO2; AURA17; DARDARIN
|
|
LRRK2 (G2019S)
|
|
|
|
NV3411
|
N2630 |
|
120892
|
leucine-rich repeat kinase 2
|
PARK8; RIPK7; ROCO2; AURA17; DARDARIN
|
|
LRRK2 (I2020T)
|
|
|
|
NV3431
|
N2630 |
|
120892
|
leucine-rich repeat kinase 2
|
PARK8; RIPK7; ROCO2; AURA17; DARDARIN
|
|
LRRK2 (R1441C)
|
|
|
|
NV3421
|
N2630 |
|
120892
|
leucine-rich repeat kinase 2
|
PARK8; RIPK7; ROCO2; AURA17; DARDARIN
|
|
LTK
|
VA7483
|
VA7484
|
VA7485
|
NV1541
|
N2630 |
N2500
|
4058
|
leukocyte receptor tyrosine kinase
|
TYK1
|
|
LYN A
|
VA7486
|
VA7487
|
VA7488
|
NV1551
|
N2520 |
N2520
|
4067
|
LYN A proto-oncogene, Src family tyrosine kinase
|
JTK8, p53Lyn, p56Lyn
|
|
LYN B
|
V3711
|
V3712
|
V9501
|
NV1551
|
N2520 |
N2520
|
4067
|
LYN A proto-oncogene, Src family tyrosine kinase
|
JTK8; FLJ26625; LYN
|
|
MAP2K6
|
|
|
|
NV3441
|
N2650
|
|
|
|
|
|
MAP3K11
|
|
|
|
NV1571
|
N2500
|
N2520 |
4296
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog
|
MLK3, PTK1, SPRK, MLK-3, MEKK11
|
|
MAP3K12
|
|
|
|
NV1581
|
N2640 |
N2500
|
26404
|
mitogen-activated protein kinase kinase kinase 11
|
DLK, MEKK12, MUK, ZPK, ZPKP1
|
|
MAP3K4
|
|
|
|
NV1591
|
N2630
|
N2520 |
4216
|
mitogen-activated protein kinase kinase kinase 12
|
MAPKKK4, MEKK 4, MEKK4, MTK1, PRO0412
|
|
MAP3K13
|
|
|
|
NV3451
|
N2630
|
|
9175
|
mitogen-activated protein kinase kinase kinase 13
|
LZK, MEKK13, MLK
|
|
MAP3K4
|
|
|
|
NV1681
|
N2640 |
N2500
|
5596
|
mitogen-activated protein kinase kinase kinase 4
|
ERK-4, ERK4, PRKM4, p63-MAPK, p63MAPK
|
|
MAPK4
|
|
|
|
NV1681
|
N2640 |
N2500
|
5596
|
mitogen-activated protein kinase 4
|
ERK-4, ERK4, PRKM4, p63-MAPK, p63MAPK
|
|
MAPK6
|
|
|
|
NV1691
|
N2640 |
N2500
|
5597
|
mitogen-activated protein kinase 6
|
ERK3, HsT17250, PRKM6, p97MAPK
|
|
MAPKAPK2
|
V4024
|
V6443
|
V4025
|
|
|
|
9261
|
mitogen-activated protein kinase-activated protein kinase 2
|
MK2; MK-2; MAPKAP-K2
|
|
MAPKAPK3
|
V4026
|
V6444
|
V4027
|
|
|
|
7867
|
mitogen-activated protein kinase-activated protein kinase 3
|
3PK; MK-3; MAPKAP3; MAPKAP-K3; MAPKAPK-3
|
|
MAPKAPK5
|
V4166
|
V6445
|
V4167
|
|
|
|
8550
|
mitogen-activated protein kinase-activated protein kinase 5
|
MK5; MK-5; PRAK; MAPKAP-K5
|
|
MARK1
|
V4028
|
V6446
|
V4029
|
|
|
|
4139
|
MAP/microtubule affinity-regulating kinase 1
|
MARK; Par1c; Par-1c; KIAA1477; MGC126512; MGC126513
|
|
MARK2
|
VA7213
|
VA7214
|
VA7215
|
NV1721
|
N2630 |
N2500
|
2011
|
microtubule affinity regulating kinase 2
|
EMK-1, EMK1, PAR-1, Par-1b, Par1b
|
|
MARK3
|
VA7489
|
VA7490
|
VA7491
|
NV3521
|
N2630 |
|
4140
|
microtubule affinity regulating kinase 3
|
CTAK1, KP78, PAR1A, Par-1a, VIPB
|
|
MARK4
|
VA7492
|
VA7493
|
VA7494
|
NV1731
|
N2640 |
N2500
|
57787
|
microtubule affinity regulating kinase 4
|
MARK4LS, MARKL1, MARKL1L, PAR-1D, MARK4
|
|
MAST3
|
|
|
|
NV3531
|
N2640 |
|
23031
|
microtubule associated serine/threonine kinase 3
|
|
|
MAST4
|
|
|
|
NV3541
|
N2640 |
|
375449
|
microtubule associated serine/threonine kinase family member 4
|
|
|
MASTL
|
VA7495
|
VA7496
|
VA7497
|
|
|
|
84930
|
microtubule associated serine/threonine kinase like
|
GREATWALL, GW, GWL, MAST-L, THC2
|
|
MEK1
|
VA7216
|
VA7217
|
VA7218
|
|
|
|
854533
|
serine/threonine protein kinase MEK1
|
MRE4
|
|
MEK4 (MAP2K4)
|
VA7219
|
VA7220
|
VA7221
|
|
|
|
6416
|
mitogen-activated protein kinase kinase 4
|
JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 6
|
|
MEK5
|
VA7222
|
VA7223
|
VA7224
|
|
|
|
5607
|
mitogen-activated protein kinase kinase 5
|
MAP2K5, sT17454, MAPKK5, PRKMK5
|
|
MEKK2
|
|
|
|
NV3471
|
N2640 |
|
10746
|
mitogen-activated protein kinase kinase kinase 2
|
MEKK2, MEKK2B
|
|
MEKK3
|
VA7498
|
VA7499
|
VA7500
|
NV3491
|
N2640 |
|
4215
|
mitogen-activated protein kinase kinase kinase 3
|
MAPKKK3, MAP3K3
|
|
MELK
|
V4150
|
V6447
|
V4151
|
NV1741
|
N2630 |
N2500
|
9833
|
maternal embryonic leucine zipper kinase
|
HPK38; KIAA0175
|
|
MELK (T460M)
|
|
|
|
NV3551
|
N2630 |
|
9833
|
maternal embryonic leucine zipper kinase
|
HPK38; KIAA0175
|
|
MET
|
V3361
|
V3362
|
V9571
|
NV1751
|
N2640 |
N2500
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (D1228H)
|
VA7225
|
VA7226
|
VA7227
|
NV3691
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (D1228N)
|
VA7228
|
VA7229
|
VA7230
|
NV3681
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (F1200I)
|
VA7231
|
VA7232
|
VA7233
|
NV3701
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (K1244R)
|
VA7234
|
VA7235
|
VA7236
|
|
|
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (M1250T)
|
V4168
|
V6448
|
V4169
|
NV3581
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met
|
|
MET (P991S)
|
VA7237
|
VA7238
|
VA7239
|
NV3601
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (T1173I)
|
|
|
|
NV3621
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (T992I)
|
|
|
|
NV3611
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (V1092I)
|
|
|
|
NV3631
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (Y1230A)
|
|
|
|
NV3641
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (Y1230C)
|
VA7501
|
VA7502
|
VA7503
|
NV3651
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (Y1230D)
|
|
|
|
NV3661
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (Y1230H)
|
VA7240
|
VA7241
|
VA7242
|
NV3671
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MET (Y1235D)
|
|
|
|
NV3591
|
N2640 |
|
4233
|
met proto-oncogene (hepatocyte growth factor receptor)
|
HGFR; AUTS9; RCCP2; c-Met; MET
|
|
MINK1
|
V3911
|
V3912
|
V8001
|
|
|
|
50488
|
misshapen like kinase 1
|
B55; ZC3; MINK; YSK2; hMINK; MAP4K6; MGC21111; hMINKbeta; MINK1
|
|
MKNK2
|
|
|
|
NV3711
|
N2640 |
|
2872
|
MAPK interacting serine/threonine kinase 2
|
GPRK7, MNK2
|
|
MLCK
|
V4496
|
V6588
|
V4497
|
|
|
|
4638
|
myosin light chain kinase
|
KRP; AAT7; MYLK; MLCK1; MMIHS; MYLK1; smMLCK; MLCK108; MLCK210; MSTP083
|
|
MLK1
|
V4072
|
V6449
|
V4073
|
NV1601
|
N2640 |
N2500
|
4293
|
mitogen-activated protein kinase kinase kinase 9
|
MEKK9; PRKE1; MAP3K9
|
|
MLK2
|
V4476
|
V6450
|
V4477
|
NV1561
|
N2640 |
N2500
|
4294
|
mitogen-activated protein kinase kinase kinase 10
|
MST; MAP3K10; MEKK10
|
|
MLK4
|
VA7504
|
VA7505
|
VA7506
|
NV3481
|
N2640 |
|
84451
|
mitogen-activated protein kinase kinase kinase 21
|
dJ862P8.3, MAP3K21
|
|
MOK
|
|
|
|
NV3731
|
N2640 |
|
5891
|
MOK protein kinase
|
RAGE, RAGE-1, RAGE1, STK30
|
|
MRCKα
|
V5710
|
V6589
|
V5711
|
|
|
|
8476
|
CDC42 binding protein kinase alpha (DMPK-like)
|
CDC42BPA, MRCK, PK428
|
|
MRCKβ
|
VA7243
|
VA7244
|
VA7245
|
|
|
|
9578
|
CDC42 binding protein kinase beta
|
CDC42BPB; MRCKbeta
|
|
MSK1
|
V5092
|
V6590
|
V5093
|
|
|
|
9252
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
RLPK; MSPK1, RPS6KA5
|
|
MSK2 (Human)
|
|
|
|
NV2011
|
N2640 |
N2500
|
8986
|
ribosomal protein S6 kinase A4
|
MSK2; RSK-B; S6K-alpha-4
|
|
MSK2 (mouse)
|
V5080
|
V6591
|
V5081
|
|
|
|
56613
|
ribosomal protein S6 kinase, polypeptide 4
|
90kDa; mMSK2; AI848992; 1110069D02Rik, RPS6KA4
|
|
MSSK1
|
VA7507
|
VA7508
|
VA7509
|
|
|
|
26576
|
SRSF protein kinase 3
|
MSSK-1, MSSK1, STK23, SRPK3
|
|
MST1
|
V4152
|
V6451
|
V4153
|
NV4351
|
N2640 |
|
6789
|
serine/threonine kinase 4
|
KRS2; STK4; YSK3; DKFZp686A2068
|
|
MUSK
|
|
|
|
NV1761
|
N2640 |
N2500
|
18198
|
muscle associated receptor tyrosine kinase
|
CMS9, FADS
|
|
MYLK2
|
VA7510
|
VA7511
|
VA7512
|
NV1771
|
N2640 |
N2500
|
85366
|
myosin light chain kinase 2
|
KMLC, MLCK, MLCK2, skMLCK
|
|
MYLK3
|
|
|
|
NV3741
|
N2640 |
|
91807
|
myosin light chain kinase 3
|
MLCK2; caMLCK
|
|
MYLK4
|
|
|
|
NV3751
|
N2640 |
|
340156
|
myosin light chain kinase family member 4
|
SgK085
|
|
MYO3β
|
V4074
|
V6452
|
V4075
|
|
|
|
140469
|
myosin IIIB
|
MYO3B
|
|
NEK1
|
VA7588
|
VA7589
|
VA7590
|
NV3761
|
N2640 |
|
4750
|
NIMA-related expressed kinase 1
|
D8Ertd790e, kat
|
|
NEK2
|
V3871
|
V3872
|
V9231
|
NV1781
|
N2640 |
N2500
|
4751
|
NIMA related kinase 1
|
ALS24; SRPS2; SRTD6; SRPS2A; NY-REN-55
|
|
NEK3
|
V4500
|
V6592
|
V4501
|
NV1791
|
N2640 |
N2500
|
4752
|
NIMA-related kinase 3
|
HSPK36
|
|
NEK4
|
|
|
|
NV3781
|
N2640 |
|
6787
|
NIMA related kinase 4
|
NRK2, STK2, pp12301
|
|
NEK5
|
VA7246
|
VA7247
|
VA7248
|
NV3791
|
N2640 |
|
341676
|
NIMA related kinase 5
|
|
|
NEK6
|
|
|
|
NV3801
|
N2630 |
|
10783
|
NIMA related kinase 6
|
SID6-1512
|
|
NEK7
|
VA7513
|
VA7514
|
VA7515
|
|
|
|
140609
|
NIMA related kinase 7
|
|
|
NEK9
|
VA7516
|
VA7517
|
VA7518
|
NV1801
|
N2640 |
N2500
|
91754
|
NIMA related kinase 9
|
APUG, LCCS10, NC, NERCC, NERCC1
|
|
NEK11
|
|
|
|
NV3771
|
N2640 |
|
79858
|
NIMA related kinase 11
|
|
|
NIK
|
V4076
|
V6453
|
V4077
|
|
|
|
9020
|
mitogen-activated protein kinase kinase kinase 14
|
HS; MAP3K14; HSNIK; FTDCR1B
|
|
NIM1
|
VA7249
|
VA7250
|
VA7251
|
NV3811
|
N2640 |
|
167359
|
NIM1 serine/threonine protein kinase
|
NIM1K; E130304F04Rik
|
|
NLK
|
|
|
|
NV3821
|
N2640 |
|
51701
|
nemo like kinase
|
|
|
NRK
|
|
|
|
NV3831
|
N2640 |
|
203447
|
Nik related kinase
|
NESK
|
|
NUAK1
|
VA7252
|
VA7253
|
VA7254
|
NV1831
|
N2640 |
N2500
|
9891
|
NUAK family kinase 1
|
ARK5
|
|
NUAK2
|
V5096
|
V6593
|
V5097
|
NV3851
|
N2640 |
|
81788
|
NUAK family, SNF1-like kinase, 2
|
SNARK
|
|
p38α
|
V2701
|
V2702
|
V9591
|
NV1661
|
N2520 |
N2520
|
1432
|
mitogen-activated protein kinase 14
|
RK; p38; EXIP; Mxi2; CSBP1; CSBP2; CSPB1; PRKM14; PRKM15; SAPK2A; p38ALPHA; MAPK14
|
|
p38α (T106A)
|
|
|
|
NV3511
|
N2640 |
|
1432
|
mitogen-activated protein kinase 14
|
RK; p38; EXIP; Mxi2; CSBP1; CSBP2; CSPB1; PRKM14; PRKM15; SAPK2A; p38ALPHA; MAPK14
|
|
p38β
|
V4154
|
V6454
|
V4155
|
NV1651
|
N2520 |
N2520
|
5600
|
mitogen-activated protein kinase 11
|
P38B; SAPK2; p38-2; PRKM11; SAPK2B; p38Beta; P38BETA2; MAPK11
|
|
p38γ
|
V3371
|
V3372
|
V9601
|
|
|
|
6300
|
mitogen-activated protein kinase 12
|
ERK3; ERK6; SAPK3; PRKM12; SAPK-3; P38GAMMA; MAPK12
|
|
p38δ
|
V4078
|
V6455
|
V4079
|
|
|
|
5603
|
mitogen-activated protein kinase 13
|
SAPK4; PRKM13; p38delta; MGC99536
|
|
p70S6K
|
V2741
|
V2742
|
V9611
|
|
|
|
6198
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
S6K; PS6K; S6K1; STK14A; p70-S6K; p70-alpha; p70(S6K)-alpha; RPS6KB1
|
|
p70S6Kb
|
V4030
|
V6456
|
V4031
|
|
|
|
6199
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
KLS; SRK; S6K2; STK14B; RPS6KB2; P70-beta; S6K-beta2; P70-beta-1; P70-beta-2; p70(S6K)-beta
|
|
PAK1
|
VA7519
|
VA7520
|
VA7521
|
|
|
|
5058
|
p21 (RAC1) activated kinase 1
|
IDDMSSD, PAKalpha
|
|
PAK1/CDC42
|
V4478
|
V6457
|
V4479
|
|
|
|
5058
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
PAKalpha; MGC130000; MGC130001
|
|
PAK3
|
V4080
|
V6458
|
V4081
|
|
|
|
18481
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
Stk4; PAK-3; Pak65beta; Pak65alpha
|
|
PAK4
|
V3201
|
V3202
|
V9451
|
NV1841
|
N2640 |
N2500
|
10298
|
p21 (RAC1) activated kinase 4
|
PAK4
|
|
PAK6
|
VA7522
|
VA7523
|
VA7524
|
NV3861
|
N2640 |
|
56924
|
p21 (RAC1) activated kinase 6
|
|
|
PAK7
|
VA7525
|
VA7526
|
VA7527
|
NV1851
|
|
N2500
|
57144
|
p21 (RAC1) activated kinase 5
|
PAK5
|
|
PASK
|
V4240
|
V6459
|
V4241
|
|
|
|
23178
|
PAS domain containing serine/threonine kinase
|
STK37; PASKIN; KIAA0135; DKFZp434O051; DKFZp686P2031
|
|
PDGFRα
|
V3721
|
V3722
|
V8011
|
|
|
|
5156
|
platelet-derived growth factor receptor, alpha polypeptide
|
CD140A; PDGFR2; MGC74795; RHEPDGFRA; PDGFRA
|
|
PDGFRα (D842V)
|
V4480
|
V6470
|
V4481
|
|
|
|
5156
|
platelet-derived growth factor receptor, alpha polypeptide
|
CD140A; PDGFR2; PDGFR-2; RHEPDGFRA
|
|
PDGFRα (T674I)
|
V4486
|
V6594
|
V4487
|
|
|
|
5156
|
platelet-derived growth factor receptor, alpha polypeptide
|
CD140A; PDGFR2; PDGFR-2; RHEPDGFRA; MGC74795
|
|
PDGFRα (V561D)
|
|
|
|
NV3871
|
N2520 |
|
5292
|
pim-1 oncogene
|
PIM
|
|
PDGFRβ
|
V3731
|
V3732
|
V8021
|
|
|
|
5159
|
platelet-derived growth factor receptor, beta polypeptide
|
JTK12; PDGFR; CD140B; PDGFR1; PDGFRB
|
|
PDK1
|
V2761
|
V2762
|
V9681
|
|
|
|
5170
|
3-phosphoinositide dependent protein kinase-1
|
PDK1; PRO0461; MGC20087; MGC35290; PDPK1
|
|
PHKG1
|
VA7528
|
VA7529
|
VA7530
|
NV1861
|
N2640 |
N2500
|
5260
|
phosphorylase kinase catalytic subunit gamma 1
|
PHKG
|
|
PHKG1
|
|
|
|
NV3881
|
N2640 |
|
5261
|
phosphorylase kinase catalytic subunit gamma 2
|
GSD9C
|
|
PIK3C3
|
|
|
|
NV3891
|
N2630 |
|
5289
|
phosphatidylinositol 3-kinase catalytic subunit type 3
|
VPS34, Vps34, hVps34
|
|
PIK3CA (C420R)/PIK3R1
|
|
|
|
PIK3CA (C420R): NV3911
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5292
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA (E542K)/PIK3R1
|
|
|
|
PIK3CA (E542K): NV3921
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA (E545A)/PIK3R1
|
|
|
|
PIK3CA (E545A): NV3931
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA (E545K)/PIK3R1
|
|
|
|
PIK3CA (E545K): NV3941
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA (H1047L)/PIK3R1
|
|
|
|
PIK3CA (H1047L): NV3951
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA (H1047R)/PIK3R1
|
|
|
|
PIK3CA (H1047R): NV3961
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA (H1047Y)/PIK3R1
|
|
|
|
PIK3CA (H1047Y): NV3971
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA (I800L)/PIK3R1
|
|
|
|
PIK3CA (I800L): NV3981
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA (M1043I)/PIK3R1
|
|
|
|
PIK3CA (M1043I): NV3991
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA (Q546K)/PIK3R1
|
|
|
|
PIK3CA (Q546K): NV4001
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CA/PIK3R1
|
|
|
|
PIK3CA: NV3901
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5290
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
CLAPO, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, PI3K-alpha, p110-alpha
|
|
PIK3CB/PIK3R1
|
|
|
|
PIK3CB: NV4011
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5291
PIK3R1: 5295
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
|
P110BETA, PI3K, PI3KBETA, PIK3C1
|
|
PIK3CD/PIK3R1
|
|
|
|
PIK3CD: NV4021
PIK3R1: NV4031
|
N2600 |
|
PIK3CA: 5293
PIK3R1: 5292
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
APDS, IMD14, P110DELTA, PI3K, p110D
|
|
PIKFYVE
|
|
|
|
NV4041
|
N2620 |
|
200576
|
phosphoinositide kinase, FYVE-type zinc finger containing
|
CFD, FAB1, HEL37, PIP5K, PIP5K3, ZFYVE29
|
|
PIM1
|
V4032
|
V6471
|
V4033
|
|
|
|
5292
|
pim-1 oncogene
|
PIM
|
|
PIM2
|
V4034
|
V6472
|
V4035
|
|
|
|
11040
|
pim-2 oncogene
|
|
|
PIM3
|
|
|
|
NV4051
|
N2640 |
|
415116
|
Pim-3 proto-oncogene, serine/threonine kinase
|
pim-3
|
|
PIP4K2C
|
|
|
|
NV4061
|
N2620 |
|
|
|
|
|
PIP5K1B
|
|
|
|
NV4071
|
N2620 |
|
|
|
|
|
PKA
|
V4246
|
NA
|
V4247
|
NV1901
|
N2640
|
N2500
|
5566
|
protein kinase cAMP-activated catalytic subunit alpha
|
PKACA; PPNAD4; PKAα
|
|
PKACβ
|
VA7255
|
VA7256
|
VA7257
|
NV4111
|
N2640
|
|
5567
|
protein kinase cAMP-activated catalytic subunit beta
|
PKA C-beta, PKACB
|
|
PKC eta
|
VA7531
|
VA7532
|
VA7533
|
|
|
|
100152637
|
protein kinase C eta
|
PKC
|
|
PKC nu
|
VA7534
|
VA7535
|
VA7536
|
|
|
|
23683
|
protein kinase D3
|
EPK2, PKC-NU, PKD3, PRKCN, nPKC-NU
|
|
PKCα
|
V3381
|
V3382
|
V9691
|
|
|
|
5578
|
protein kinase C, alpha
|
AAG6; PKCA; PRKACA; MGC129900; MGC129901; PKC-alpha; PRKCA
|
|
PKCβII
|
V3741
|
V3742
|
V9701
|
|
|
|
5579
|
protein kinase C, beta
|
PKCB; PRKCB1; PRKCB2; MGC41878; PKC-beta; PRKCB
|
|
PKCβI
|
V5094
|
V6595
|
V5095
|
|
|
|
5579
|
protein kinase C, beta I
|
PKCB; PRKCB1; PRKCB2; PKC-beta
|
|
PKCγ
|
V3391
|
V3392
|
V9711
|
|
|
|
5582
|
protein kinase C, gamma
|
PKCC; PKCG; SCA14; MGC57564; PKC-gamma; PRKCG
|
|
PKCδ
|
V3401
|
V3402
|
V9721
|
|
|
|
5580
|
protein kinase C, delta
|
MAY1; PKCD; MGC49908; nPKC-delta; PRKCD
|
|
PKCε
|
V4036
|
V6473
|
V4037
|
NV4121
|
N2640
|
|
5581
|
protein kinase C, epsilon
|
PKCE; nPKC-epsilon; MGC125656; MGC125657
|
|
PKCζ
|
V2781
|
V2782
|
V9731
|
|
|
|
5590
|
protein kinase C, zeta
|
PKC2; PKC-ZETA; PRKCZ
|
|
PKCθ
|
V4040
|
V6475
|
V4041
|
|
N2630
|
|
5588
|
protein kinase C, theta
|
PRKCT; nPKC-theta; PRKCQ
|
|
PKCι
|
V3751
|
V3752
|
V9751
|
|
N2630
|
|
5584
|
protein kinase C, iota
|
PKCI; DXS1179E; MGC26534; nPKC-iota; PRKCI
|
|
PKCμ
|
V4038
|
V6474
|
V4039
|
|
|
|
5587
|
protein kinase D1
|
PKD; PKCM; PRKCM; PKC-MU; PRKD1
|
|
PKD2
|
V4042
|
V6476
|
V4043
|
|
|
|
25865
|
protein kinase D2
|
HSPC187; nPKC-D2; PRKD2
|
|
PKMYT1
|
|
|
|
NV1871
|
N2640
|
N2500
|
9088
|
protein kinase, membrane associated tyrosine/threonine 1
|
MYT1, PPP1R126
|
|
PLK1
|
V2841
|
V2842
|
V8041
|
|
|
|
5347
|
polo like kinase 1
|
PLK; STPK13; PLK1
|
|
PLK2
|
VA7537
|
VA7538
|
VA7539
|
NV4081
|
N2630
|
|
10769
|
polo like kinase 2
|
SNK, hPlk2, hSNK
|
|
PLK3
|
VA7540
|
VA7541
|
VA7542
|
NV4091
|
N2630
|
|
1263
|
polo like kinase 3
|
CNK, FNK, PLK-3, PRK
|
|
PLK4
|
VA7258
|
VA7259
|
VA7260
|
NV1881
|
N2640
|
N2500
|
10733
|
polo like kinase 4
|
MCCRP2, SAK, STK18
|
|
PRKAA1
|
see AMPK
|
see AMPK
|
see AMPK
|
NV4101
|
N2640
|
|
5562
|
protein kinase AMP-activated catalytic subunit alpha 1
|
AMPK, AMPKa1
|
|
PRKAA2
|
|
|
|
NV1891
|
N2640
|
N2500
|
5563
|
protein kinase AMP-activated catalytic subunit alpha 2
|
AMPK, AMPK2, PRKAA, AMPKa2
|
|
PRKG2
|
|
|
|
NV4131
|
N2630
|
|
5593
|
protein kinase cGMP-dependent 2
|
PKG2, PRKGR2, cGK2, cGKII
|
|
PRKX
|
VA7543
|
VA7544
|
VA7545
|
NV1911
|
N2640
|
N2500
|
5563
|
protein kinase AMP-activated catalytic subunit alpha 2
|
AMPK, AMPK2, PRKAA, AMPKa2
|
|
PTC1 (CCDC6-RET)
|
VA7261
|
VA7262
|
VA7263
|
|
|
|
CCDC6: 8030
RET: 5979
|
coiled-coil domain containing 6
ret proto-oncogene
|
CCDC6- D10S170, H4, PTC, TPC, TST1
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
PTC3 (NCOA4-RET)
|
VA7264
|
VA7265
|
VA7266
|
|
|
|
NCOA4: 8031
RET: 5979
|
nuclear receptor coactivator 4
ret proto-oncogene
|
NCOA4- ARA70, ELE1, PTC3, RFG
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
PYK2
|
V4082
|
V6477
|
V4083
|
NV1931
|
N2640
|
N2500
|
2185
|
PTK2B protein tyrosine kinase 2 beta
|
PKB; PTK; CAKB; FAK2; PTK2B; CADTK; FADK2; RAFTK
|
|
QIK
|
VA7267
|
VA7268
|
VA7269
|
NV2061
|
N2640
|
N2500
|
23235
|
salt inducible kinase 2
|
SIK2, LOH11CR1I, SIK-2, SNF1LK2
|
|
RET
|
V3761
|
V3762
|
V8061
|
NV1951
|
N2640
|
N2500
|
5979
|
ret proto-oncogene
|
PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
RET (A883F)
|
VA7270
|
VA7271
|
VA7272
|
|
|
|
5979
|
ret proto-oncogene
|
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
RET (M918T)
|
VA7273
|
VA7274
|
VA7275
|
NV4141
|
N2640
|
|
5979
|
ret proto-oncogene
|
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
RET (R749T)
|
VA7276
|
VA7277
|
VA7278
|
|
|
|
5979
|
ret proto-oncogene
|
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
RET (R813Q)
|
VA7279
|
VA7280
|
VA7281
|
|
|
|
5979
|
ret proto-oncogene
|
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
RET (R912P)
|
VA7282
|
VA7283
|
VA7284
|
|
|
|
5979
|
ret proto-oncogene
|
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
RET (S904A)
|
VA7285
|
VA7286
|
VA7284
|
|
|
|
5979
|
ret proto-oncogene
|
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
RET (S904F)
|
VA7288
|
VA7289
|
VA7290
|
|
|
|
5979
|
ret proto-oncogene
|
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
RET (V778I)
|
VA7291
|
VA7292
|
VA7293
|
|
|
|
5979
|
ret proto-oncogene
|
RET- PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1; RET
|
|
RET (V804L)
|
V4472
|
V6596
|
V4473
|
NV4151
|
N2640
|
|
5979
|
ret proto-oncogene
|
PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1
|
|
RET (V804M)
|
|
|
|
NV4161
|
N2640
|
|
5979
|
ret proto-oncogene
|
PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1
|
|
RET (Y791F)
|
V5326
|
V6597
|
V5327
|
|
|
|
5979
|
ret proto-oncogene
|
PTC; MTC1; HSCR1; MEN2A; MEN2B; RET51; CDHF12; CDHR16; RET-ELE1
|
|
RIOK2
|
|
|
|
NV1961
|
N2640
|
N2500
|
55781
|
RIO kinase 2
|
RIO2
|
|
RIPK1 (1-327)
|
VA7591
|
VA7592
|
VA7593
|
NV4171
|
N2630
|
|
8737
|
receptor interacting serine/threonine kinase 1
|
IMD57, RIP, RIP-1, RIP1
|
|
RIPK2
|
V4084
|
V6478
|
V4085
|
NV1971
|
N2640 |
N2520
|
8767
|
receptor interacting serine/threonine kinase 2
|
CCK; RICK; RIP2; CARD3; GIG30; CARDIAK
|
|
ROCK1
|
V3411
|
V3412
|
V9581
|
|
|
|
6093
|
Rho-associated, coiled-coil containing protein kinase 1
|
PRO0435; MGC43611; P160ROCK; MGC131603; ROCK1
|
|
ROCK2
|
V4044
|
V6479
|
V4045
|
|
|
|
9475
|
Rho-associated, coiled-coil containing protein kinase 2
|
ROCK-II
|
|
RON
|
V3921
|
V3922
|
V8071
|
NV4181
|
N2630
|
|
4486
|
macrophage stimulating 1 receptor (c-met-related tyrosine kinase)
|
RON; PTK8; CD136; CDw136; MST1R
|
|
ROS1
|
VA7546
|
VA7547
|
VA7548
|
|
|
|
6098
|
ROS proto-oncogene 1, receptor tyrosine kinase
|
ROS; MCF3; c-ros-1
|
|
ROS1 (G2032R)
|
VA7294
|
VA7295
|
VA7296
|
|
|
|
6098
|
ROS proto-oncogene 1, receptor tyrosine kinase
|
ROS; MCF3; c-ros-1
|
|
RSK1
|
V4046
|
V6560
|
V4047
|
NV1981
|
N2640
|
N2500
|
6195
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
RSK; HU-1; RPS6KA1; MAPKAPK1A
|
|
RSK2
|
V3501
|
V3502
|
V9651
|
NV2001
|
N2640
|
N2500
|
6197
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
CLS; RSK; HU-3; RSK2; MRX19; ISPK-1; p90-RSK2; pp90RSK2; MAPKAPK1B; S6K-alpha3; RPS6KA3
|
|
RSK2 (I416V)
|
|
|
|
NV4191
|
N2640
|
|
6197
|
ribosomal protein S6 kinase A3
|
CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RPS6KA3, S6K-alpha3, p90-RSK2, pp90RSK2
|
|
RSK2 (L608F)
|
VA7297
|
VA7298
|
VA7299
|
NV4201
|
N2640
|
|
6197
|
ribosomal protein S6 kinase A3
|
CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RPS6KA3, S6K-alpha3, p90-RSK2, pp90RSK2
|
|
RSK3
|
VA7549
|
VA7550
|
VA7551
|
NV1991
|
N2640
|
N2500
|
6196
|
ribosomal protein S6 kinase A2
|
RPS6KA2, HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2, p90-RSK3, p90RSK2, pp90RSK3
|
|
RSK4
|
VA7552
|
VA7553
|
VA7554
|
NV2021
|
N2640
|
N2500
|
27330
|
ribosomal protein S6 kinase A6
|
RPS6KA6, PP90RSK4, RSK-4, RSK4, S6K-alpha-6, p90RSK6
|
|
SBK1
|
VA7363
|
VA7364
|
VA7365
|
|
|
|
388228
|
SH3 domain binding kinase 1
|
SBK
|
|
SBK3
|
|
|
|
NV4211
|
N2640
|
|
100130827
|
SH3 domain binding kinase family member 3
|
SGK110
|
|
SGK1
|
V2911
|
V2912
|
V9671
|
NV4221
|
N2640
|
|
6446
|
serum/glucocorticoid regulated kinase 1
|
SGK; SGK1
|
|
SGK2
|
VA7555
|
VA7556
|
VA7557
|
NV4231
|
N2630
|
|
10110
|
serum/glucocorticoid regulated kinase 2
|
H-SGK2, dJ138B7.2
|
|
SIK
|
V4156
|
V6561
|
V4157
|
NV2031
|
N2640
|
N2520
|
150094
|
salt-inducible kinase 1
|
MSK; SIK1; SNF1LK
|
|
SIK3
|
VA7300
|
VA7301
|
VA7302
|
NV2041
|
N2640
|
N2520
|
23387
|
SIK family kinase 3
|
L19, QSK, SEMDK, SIK-3
|
|
SLK
|
V4242
|
V6562
|
V4243
|
NV2051
|
N2640
|
N2500
|
9748
|
STE20-like kinase
|
LOSK; STK2; se20-9; bA16H23.1
|
|
SNRK
|
|
|
|
NV4241
|
N2640
|
|
54861
|
SNF related kinase
|
HSNFRK
|
|
SPHK2
|
VA7600
|
VA7601
|
VA7602
|
|
|
|
56848
|
sphingosine kinase 2
|
SK 2, SK-2, SPK 2, SPK-2
|
|
SRC
|
V2921
|
V2922
|
V9741
|
NV2071
|
N2500
|
N2520
|
6714
|
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog
|
ASV; SRC1; c-SRC; p60-Src; SRC
|
|
SRMS
|
|
|
|
NV4251
|
N2640
|
|
6725
|
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristoylation sites
|
C20orf148, PTK70, SRM, dJ697K14.1
|
|
SRPK1
|
VA7558
|
VA7559
|
VA7560
|
|
|
|
6732
|
SRSF protein kinase 1
|
SFRSK1
|
|
SRPK2
|
VA7561
|
VA7562
|
VA7563
|
|
|
|
6733
|
SRSF protein kinase 2
|
SFRSK2
|
|
STK10
|
|
|
|
NV4261
|
N2640
|
|
6793
|
serine/threonine kinase 10
|
LOK, PRO2729
|
|
STK11
|
|
|
|
NV2081
|
N2640
|
N2500
|
6794
|
serine/threonine kinase 11
|
LKB1, PJS, hLKB1
|
|
STK16
|
|
|
|
NV2091
|
N2640
|
N2500
|
8576
|
serine/threonine kinase 16
|
KRCT, MPSK, PKL12, PSK, TSF1, hPSK
|
|
STK24
|
|
|
|
NV4281
|
N2630
|
|
8428
|
serine/threonine kinase 24
|
HEL-S-95, MST3, MST3B, STE20, STK3
|
|
STK26
|
|
|
|
NV4291
|
N2630
|
|
51765
|
serine/threonine kinase 26
|
MASK, MST4
|
|
STK3
|
VA7564
|
VA7565
|
VA7566
|
NV4301
|
N2640
|
|
6788
|
serine/threonine kinase 3
|
KRS1, MST2
|
|
STK32A
|
|
|
|
NV4311
|
N2630
|
|
202374
|
serine/threonine kinase 32A
|
YANK1
|
|
STK32B
|
|
|
|
NV2101
|
N2630
|
N2500
|
55351
|
serine/threonine kinase 32B
|
HSA250839, STK32, STKG6, YANK2
|
|
STK33
|
V4086
|
V6563
|
V4087
|
NV2111
|
N2640
|
N2500
|
65975
|
serine/threonine kinase 33
|
|
|
STK35
|
|
|
|
NV4321
|
N2640
|
|
140901
|
serine/threonine kinase 35
|
CLIK1, STK35L1
|
|
STK36
|
|
|
|
NV4331
|
N2640
|
|
27148
|
serine/threonine kinase 36
|
FU
|
|
STK38
|
|
|
|
NV2121
|
N2640
|
N2500
|
11329
|
serine/threonine kinase 38
|
NDR, NDR1
|
|
STK38L
|
|
|
|
NV4341
|
N2640
|
|
23012
|
serine/threonine kinase 38 like
|
NDR2
|
|
SYK
|
V3801
|
V3802
|
V8271
|
|
|
|
6850
|
spleen tyrosine kinase
|
FLJ25043; FLJ37489; DKFZp313N1010; SYK
|
|
TAK1-TAB1
|
V4088
|
V6564
|
V4089
|
|
|
|
TAK1: 6885
TAB1: 10454
|
TAK1: mitogen-activated protein kinase kinase kinase 7
TAB1: TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
|
TAOK1
|
V4090
|
V6565
|
V4091
|
|
|
|
57551
|
TAO kinase 1
|
PSK2; TAO1; KFC-B; MARKK; PSK-2; hKFC-B; hTAOK1; MAP3K16
|
|
TAOK2
|
VA7303
|
VA7304
|
VA7305
|
|
|
|
9344
|
TAO kinase 2
|
MAP3K17, PSK, PSK1, PSK1-BETA, TAO1, TAO2
|
|
TBK1
|
V3991
|
V3992
|
V8291
|
NV2131
|
N2640
|
N2500
|
29110
|
TANK binding kinase 1
|
NAK; T2K; FLJ11330; TBK1
|
|
TEC
|
VA7306
|
VA7307
|
VA7308
|
NV2141
|
N2520
|
N2520
|
7006
|
tec protein tyrosine kinase
|
PSCTK4
|
|
TESK1
|
|
|
|
NV2161
|
N2520
|
N2520
|
7016
|
testis-specific kinase 1
|
|
|
TGFβR1
|
V4092
|
V6566
|
V4093
|
|
|
|
7046
|
transforming growth factor, beta receptor 1
|
AAT5; ALK5; MSSE; SKR4; ALK-5; LDS1A; LDS2A; TGFR-1; ACVRLK4
|
|
TGFβR2
|
V3931
|
V3932
|
V8301
|
NV4421
|
N2650
|
|
7048
|
transforming growth factor beta receptor 2
|
AAT3; FAA3; MFS2; RIIC; LDS1B; LDS2B; TAAD2; TGFR-2; TGFbeta-RII; TGFBR2
|
|
TIE1
|
|
|
|
NV2171
|
N2640
|
N2500
|
7075
|
tyrosine kinase with immunoglobulin like and EGF like domains 1
|
JTK14, TIE
|
|
TIE2
|
VA7366
|
VA7367
|
VA7368
|
NV2151
|
N2640
|
N2500
|
7010
|
TEK receptor tyrosine kinase
|
TEK; VMCM; GLC3E; TIE-2; VMCM1; CD202B
|
|
TIE2 (A1124V)
|
|
|
|
NV4361
|
N2640
|
|
7010
|
TEK receptor tyrosine kinase
|
TEK; VMCM; GLC3E; TIE-2; VMCM1; CD202B
|
|
TIE2 (P883A)
|
|
|
|
NV4371
|
N2640
|
|
7010
|
TEK receptor tyrosine kinase
|
TEK; VMCM; GLC3E; TIE-2; VMCM1; CD202B
|
|
TIE2 (R849W)
|
VA7309
|
VA7310
|
VA7311
|
NV4381
|
N2640
|
|
7010
|
TEK receptor tyrosine kinase
|
TEK; VMCM; GLC3E; TIE-2; VMCM1; CD202B
|
|
TIE2 (R915C)
|
VA7312
|
VA7313
|
VA7314
|
|
|
|
7010
|
TEK receptor tyrosine kinase
|
TEK; VMCM; GLC3E; TIE-2; VMCM1; CD202B
|
|
TIE2 (Y1108F)
|
|
|
|
NV4391
|
N2640
|
|
7010
|
TEK receptor tyrosine kinase
|
TEK; VMCM; GLC3E; TIE-2; VMCM1; CD202B
|
|
TIE2 (Y897H R915C)
|
VA7603
|
VA7604
|
VA7605
|
|
N2640
|
|
7010
|
TEK receptor tyrosine kinase
|
TEK; VMCM; GLC3E; TIE-2; VMCM1; CD202B
|
|
TIE2 (Y897C)
|
VA7603
|
VA7604
|
VA7605
|
NV4401
|
N2640
|
|
7010
|
TEK receptor tyrosine kinase
|
TEK; VMCM; GLC3E; TIE-2; VMCM1; CD202B
|
|
TIE2 (Y897S)
|
VA7315
|
VA7316
|
VA7317
|
NV4411
|
N2640
|
|
7010
|
TEK receptor tyrosine kinase
|
TEK; VMCM; GLC3E; TIE-2; VMCM1; CD202B
|
|
TLK1
|
|
|
|
NV4431
|
N2640
|
|
9874
|
tousled like kinase 1
|
PKU-beta
|
|
TLK2
|
|
|
|
NV4441
|
N2640
|
|
11011
|
tousled like kinase 2
|
HsHPK, MRD57, PKU-ALPHA
|
|
TMP3-ROS1
|
VA7318
|
VA7319
|
VA7320
|
|
|
|
71706098
|
tropomyosin 3
ROS proto-oncogene 1, receptor tyrosine kinase
|
TMP3- CAPM1, CFTD, HEL-189, HEL-S-82p, NEM1, OK/SW-cl.5, TM-5, TM3, TM30, TM30nm, TM5nu, TPMsk3, TRK, hscp30, TPM3
ROS1- ROS; MCF3; c-ros-1
|
|
TNIK
|
V4158
|
V6567
|
V4159
|
|
|
|
23043
|
TRAF2 and NCK interacting kinase
|
|
|
TNK1
|
VA7321
|
VA7322
|
VA7323
|
NV2181
|
N2640
|
N2500
|
8711
|
tyrosine kinase non receptor 1
|
|
|
TNK2
|
|
|
|
NV4451
|
N2640
|
|
10188
|
tyrosine kinase non receptor 1
|
ACK, ACK-1, ACK1, p21cdc42Hs
|
|
TNNI3K
|
|
|
|
NV4461
|
N2640
|
|
51086
|
TNNI3 interacting kinase
|
CARK, CCDD
|
|
TOPK
|
V4094
|
V6568
|
V4095
|
|
|
|
55872
|
PDZ binding kinase
|
SPK; CT84; PBK; Nori-3
|
|
TPR-TRKA (TRK-T1)
|
VA7324
|
VA7325
|
VA7326
|
|
|
|
71754914
|
translocated promoter region, nuclear basket protein
neurotrophic receptor tyrosine kinase 1
|
TRKA- MTC; TRK; TRK1; NTRK1; Trk-A; p140-TrkA
|
|
TRKA
|
V2931
|
V2932
|
V9761
|
NV1811
|
N2640
|
N2500
|
4914
|
neurotrophic tyrosine kinase, receptor, type 1
|
MTC; TRK; TRK1; TRKA; p140-TrkA; DKFZp781I14186; NTRK1
|
|
TRKA (A608D)
|
VA7327
|
VA7328
|
VA7329
|
|
|
|
4914
|
neurotrophic receptor tyrosine kinase 2
|
MTC; TRK; TRK1; NTRK1; Trk-A; p140-TrkA
|
|
TRKA (F589L)
|
VA7330
|
VA7331
|
VA7332
|
|
|
|
4914
|
neurotrophic receptor tyrosine kinase 2
|
MTC; TRK; TRK1; NTRK1; Trk-A; p140-TrkA
|
|
TRKA (G595R A608D)
|
VA7333
|
VA7334
|
VA7335
|
|
|
|
4914
|
neurotrophic receptor tyrosine kinase 2
|
MTC; TRK; TRK1; NTRK1; Trk-A; p140-TrkA
|
|
TRKA (G595R)
|
VA7336
|
VA7337
|
VA7338
|
|
|
|
4914
|
neurotrophic receptor tyrosine kinase 2
|
MTC; TRK; TRK1; NTRK1; Trk-A; p140-TrkA
|
|
TRKA (G667C)
|
VA7339
|
VA7340
|
VA7341
|
NV3841
|
N2640
|
|
4914
|
neurotrophic receptor tyrosine kinase 2
|
MTC; TRK; TRK1; NTRK1; Trk-A; p140-TrkA
|
|
TRKA (L657M)
|
VA7567
|
VA7568
|
VA7569
|
|
|
|
4914
|
neurotrophic receptor tyrosine kinase 2
|
MTC; TRK; TRK1; NTRK1; Trk-A; p140-TrkA
|
|
TRKB
|
V4048
|
V6569
|
V4049
|
NV1821
|
N2640
|
N2500
|
4915
|
neurotrophic tyrosine kinase, receptor, type 2
|
NTRK2; trk-B; GP145-TrkB
|
|
TRKC
|
VA7342
|
VA7343
|
VA7344
|
|
|
|
4916
|
neurotrophic receptor tyrosine kinase 3
|
GP145-TrkC, NTRK3, gp145(trkC)
|
|
TRKC (G623R)
|
VA7570
|
VA7571
|
VA7572
|
|
|
|
4916
|
neurotrophic receptor tyrosine kinase 3
|
GP145-TrkC, NTRK3, gp145(trkC)
|
|
TSSK1B
|
VA7345
|
VA7346
|
VA7347
|
NV4471
|
N2630
|
|
83942
|
testis specific serine kinase 1B
|
FKSG81, SPOGA4, STK22D, TSK1, TSSK1
|
|
TSSK2
|
VA7573
|
VA7574
|
VA7575
|
|
|
|
23617
|
testis specific serine kinase 2
|
DGS-G, SPOGA2, STK22B, TSK2
|
|
TTK
|
|
|
|
NV2191
|
N2630
|
N2500
|
7272
|
TTK protein kinase
|
CT96, ESK, MPH1, MPS1, MPS1L1, PYT
|
|
TXK
|
VA7576
|
VA7577
|
VA7578
|
NV2201
|
N2620
|
N2520
|
7294
|
TTK protein kinase
|
RLK; TKL; BTKL; PTK4; PSCTK5
|
|
TYK2
|
|
|
|
NV4511
|
N2640
|
|
7294
|
tyrosine kinase 2
|
IMD35, JTK1
|
|
TYK2 (JH1 Domain)
|
|
|
|
NV4521
|
N2640
|
|
7294
|
tyrosine kinase 2
|
IMD35, JTK1
|
|
TYK2 (JH2 Domain)
|
|
|
|
NV4531
|
N2640
|
|
7294
|
tyrosine kinase 2
|
IMD35, JTK1
|
|
TYRO3
|
VA7579
|
VA7580
|
VA7581
|
NV4481
|
N2640
|
|
7301
|
TYRO3 protein tyrosine kinase
|
BYK; Dtk; RSE; Rek; Sky; Tif; Etk-2
|
|
ULK1
|
V3521
|
V3522
|
V9191
|
NV2211
|
N2640
|
N2500
|
8408
|
unc-51 like autophagy activating kinase 1
|
ATG1; ATG1A; UNC51; hATG1; Unc51.1
|
|
ULK2
|
VA7582
|
VA7583
|
VA7584
|
NV2221
|
N2640
|
N2500
|
9706
|
unc-51 like autophagy activating kinase 2
|
ATG1B, Unc51.2
|
|
ULK3
|
VA7585
|
VA7586
|
VA7587
|
NV4491
|
N2640
|
|
25989
|
unc-51 like kinase 3
|
|
|
VRK2
|
V4494
|
V6570
|
V4495
|
|
|
|
7444
|
vaccinia related kinase 2
|
|
|
WEE1
|
|
|
|
NV2231
|
N2640
|
N2500
|
7465
|
WEE1 G2 checkpoint kinase
|
WEE1Ahu
|
|
WEE2
|
|
|
|
NV4501
|
N2640
|
|
494551
|
WEE2 oocyte meiosis inhibiting kinase
|
OOMD5, WEE1B
|
|
WNK1
|
V5084
|
V6599
|
V5085
|
NV3231
|
N2640
|
|
10114
|
homeodomain interacting protein kinase 3
|
PKY; YAK1; DYRK6; FIST3
|
|
YES1
|
VA7351
|
VA7352
|
VA7353
|
NV2241
|
N2520
|
N2520
|
7525
|
YES proto-oncogene 1, Src family tyrosine kinase
|
HsT441, P61-YES, Yes, c-yes
|
|
YES1 (T348I)
|
VA7348
|
VA7349
|
VA7350
|
|
|
|
7525
|
YES proto-oncogene 1, Src family tyrosine kinase
|
HsT441, P61-YES, Yes, c-yes
|
|
YSK4
|
VA7354
|
VA7355
|
VA7356
|
NV3461
|
N2640
|
|
80122
|
mitogen-activated protein kinase kinase kinase 19
|
RCK, MAP3K19
|
|
ZAK
|
V4244
|
V6571
|
V4245
|
NV3721
|
N2640
|
|
51776
|
sterile alpha motif and leucine zipper containing kinase AZK
|
pk; AZK; MLT; MRK; MLK7; MLTK; mlklak
|
|
ZAP70
|
V3811
|
V3812
|
V8311
|
|
|
|
7535
|
zeta-chain (TCR) associated protein kinase 70kDa
|
SRK; STD; TZK; ZAP-70; FLJ17670; FLJ17679; ZAP70
|